RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: brain ischemia
Accession: DOID:2316
browse the term
Definition: An ischemia that is characterized by insufficient blood flow to the brain to meet metabolic demand. (DO)
Synonyms: exact_synonym: Cerebral Hypoperfusion; Cerebral Ischemias; Ischaemic encephalopathy; brain ischemias; cerebral ischemia; ischemic encephalopathies; ischemic encephalopathy
primary_id: MESH:D002545
xref: EFO:0003883 ; MONDO:0005299
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
IEP
RGD
PMID:15049514
RGD:1598554
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15534175
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
mRNA:increased expression:brain
RGD
PMID:17073862
RGD:9681750
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Add3
adducin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adk
adenosine kinase
ISO
RGD
PMID:21427729 PMID:17457365
RGD:6482652 , RGD:6482655
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA:increased expression:pyramidal cell, hippocampus
RGD
PMID:12618340
RGD:1625348
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:18301954
RGD:2313032
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akap1
A-kinase anchoring protein 1
IEP
protein:altered expression:parietal cortex, hippocampus (rat)
RGD
PMID:18323779
RGD:2313128
NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896
G
Akap12
A-kinase anchoring protein 12
IEP
RGD
PMID:21334414
RGD:14348963
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Akt1
AKT serine/threonine kinase 1
IEP
protein:decreased serine phosphorylation:cerebral cortex
RGD
PMID:21596097
RGD:5509066
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16809570
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox15
arachidonate 15-lipoxygenase
IEP
mRNA, protein:increased expression:brain
RGD
PMID:20167207
RGD:5509598
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
Alox5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:20204486
RGD:2317525
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Angpt1
angiopoietin 1
ISO
RGD
PMID:17637706
RGD:1643339
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Angpt2
angiopoietin 2
IDA
RGD
PMID:17494864
RGD:2314206
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
G
Anxa1
annexin A1
treatment
ISO IMP
RGD
PMID:1830327 PMID:1830327
RGD:7421662 , RGD:7421662
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Apaf1
apoptotic peptidase activating factor 1
IEP
protein:increased expression:striatum
RGD
PMID:17640469
RGD:2325742
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
IEP
protein:decreased expression:hippocampus CA1, neuron
RGD
PMID:9030714
RGD:2315686
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Aqp3
aquaporin 3 (Gill blood group)
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Aqp4
aquaporin 4
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Aqp5
aquaporin 5
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
G
Aqp8
aquaporin 8
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
G
Asic1
acid sensing ion channel subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21307247
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
G
Bad
BCL2-associated agonist of cell death
IEP
protein:decreased serine phosphorylation:brain
RGD
PMID:18078455 PMID:22843461
RGD:2292681 , RGD:10053716
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bbc3
Bcl-2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19095966
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:15585409
RGD:11522731
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:17706879 PMID:22843461
RGD:1643491 , RGD:10053716
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19922383
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
IMP IEP
protein:increased expression:hippocampus, frontal cortex
RGD
PMID:19574998 PMID:17936001
RGD:6483094 , RGD:6483313
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bmp6
bone morphogenetic protein 6
IEP
RGD
PMID:11245809
RGD:2289024
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Btg2
BTG anti-proliferation factor 2
IEP
mRNA:increased expression:forebrain (rat)
RGD
PMID:7684483
RGD:2289081
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
C3
complement C3
IEP
protein:increased expression:brain
RGD
PMID:14561876
RGD:5129543
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp12
caspase 12
IEP
mRNA, protein:increased expresssion:brain
RGD
PMID:12598725
RGD:1299333
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504 PMID:17901229
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:11311984
RGD:2301331
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp9
caspase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
IDA
RGD
PMID:16467455
RGD:5509813
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17564305 PMID:21213399
RGD:5130891
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
IEP
RGD
PMID:16417587
RGD:1581152
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccl11
C-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl12
C-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
G
Ccl2
C-C motif chemokine ligand 2
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:17394460 PMID:19260320
RGD:2306998
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:9916893
RGD:69987
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914 PMID:17394460
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccr4
C-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:9670989
RGD:632396
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd36
CD36 molecule
ISO
RGD
PMID:20360550
RGD:6893498
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cdk5
cyclin-dependent kinase 5
IMP
RGD
PMID:14502288
RGD:734740
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cebpb
CCAAT/enhancer binding protein beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17394460
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Chrm1
cholinergic receptor, muscarinic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18501976
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
IEP
RGD
PMID:16434029
RGD:1581188
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Clu
clusterin
IEP
RGD
PMID:12782389
RGD:727237
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cp
ceruloplasmin
IEP
mRNA, protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:18273071
RGD:2314688
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Creb1
cAMP responsive element binding protein 1
treatment
IEP
mRNA,protein:decreased expression,decreased phosphorylation:brain:
RGD
PMID:23644141
RGD:10059580
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:8541482
RGD:1581300
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Csf2rb
colony stimulating factor 2 receptor subunit beta
IEP
mRNA:increased expression:brain
RGD
PMID:7643220
RGD:632531
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
G
Csf3
colony stimulating factor 3
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:18832793
RGD:2311241
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cspg4
chondroitin sulfate proteoglycan 4
IEP
RGD
PMID:21864831
RGD:5686850
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
G
Cst3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:18261165
RGD:2314349
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Ctsb
cathepsin B
IEP
protein:increased activity:cerebrum (rat)
RGD
PMID:18404379
RGD:2315571
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsc
cathepsin C
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:12843783
RGD:1599640
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Ctsl
cathepsin L
IEP
protein:increased activity:cerebrum (rat)
RGD
PMID:18404379
RGD:2315571
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cxcl10
C-X-C motif chemokine ligand 10
IEP ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:17549754
RGD:2311381
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP
mRNA, protein:increased expression:brain
RGD
PMID:18206136
RGD:2306577
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cycs
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Dbh
dopamine beta-hydroxylase
IEP
protein:decreased expression:forebrain (rat)
RGD
PMID:18356740
RGD:5129691
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
G
Ddit3
DNA-damage inducible transcript 3
IEP
Protein:increased expression:brain
RGD
PMID:15921666
RGD:1599731
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Diablo
diablo, IAP-binding mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dpysl2
dihydropyrimidinase-like 2
IEP
mRNA:increased expression:brain
RGD
PMID:19524114
RGD:2316241
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
G
Drd2
dopamine receptor D2
IEP
RGD
PMID:11474153
RGD:1580883
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Dusp6
dual specificity phosphatase 6
IEP
mRNA:increased expression:brain
RGD
PMID:10908038
RGD:2316092
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dynll1
dynein light chain LC8-type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9522364
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Edn1
endothelin 1
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:8113329
RGD:4144887
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Egr1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17394460
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Endog
endonuclease G
IEP
RGD
PMID:18568342
RGD:9685367
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
G
Epor
erythropoietin receptor
IEP
protein:increased expression:brain:
RGD
PMID:14732457
RGD:11041652
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
Esr2
estrogen receptor 2
IEP
mRNA:decreased expression:cerebral cortex, ipsilateral side (rat)
RGD
PMID:10414967
RGD:8694344
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14753426 PMID:15534175
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F2r
coagulation factor II (thrombin) receptor
IEP
RGD
PMID:14705148
RGD:1302269
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
F5
coagulation factor V
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15534175
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
Fas
Fas cell surface death receptor
IEP
protein:increased expression:brain
RGD
PMID:16796407
RGD:1600333
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
IEP
protein:increased expression:brain
RGD
PMID:18410517
RGD:2311437
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fga
fibrinogen alpha chain
treatment
IDA
RGD
PMID:22737923
RGD:11040923
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgf1
fibroblast growth factor 1
IDA ISO
Rat model using human FGF1
RGD
PMID:19497570 PMID:16635575
RGD:5509879 , RGD:5509881
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Gal
galanin and GMAP prepropeptide
IEP
RGD
PMID:16458372
RGD:1624341
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Gc
GC, vitamin D binding protein
IEP
protein:increased expression:urine
RGD
PMID:11239198
RGD:1625796
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gfra1
GDNF family receptor alpha 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:10407114
RGD:6218981
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Gja1
gap junction protein, alpha 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:21718970
RGD:6480433
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Glud1
glutamate dehydrogenase 1
IEP
protein:decreased activity:brain
RGD
PMID:7808037
RGD:6484655
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Gp1ba
glycoprotein Ib platelet subunit alpha
exacerbates
ISO
associated with Pneumococcal Infections
RGD
PMID:24644058
RGD:42722626
NCBI chr10:55,352,938...55,355,804
Ensembl chr10:55,352,899...55,356,774
G
Gpx1
glutathione peroxidase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12531513
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx3
glutathione peroxidase 3
ISO
protein:increased expression:plasma
RGD
PMID:30025402
RGD:401827828
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
ISO IDA IEP
protein:increased expression:brain CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:cerebral cortex (rat)
CTD RGD
PMID:19429140 PMID:17554006 PMID:18369388 PMID:17101276
RGD:1626331 , RGD:9068895 , RGD:9068892
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
IEP IMP
RGD
PMID:16464361 PMID:21276833
RGD:1582709 , RGD:10755576
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
ISO
associated with advanced age and Diabetes Mellitus, Type 2 (MeSH:D003924)
RGD
PMID:15992611
RGD:1626649
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
RGD
PMID:16805800
RGD:6480229
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspa9
heat shock protein family A (Hsp70) member 9
IEP
mRNA:increased expression:brain
RGD
PMID:7629893
RGD:6784525
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17394460 PMID:19417757
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Igf1
insulin-like growth factor 1
IDA ISO
RGD
PMID:16882007 PMID:19332057
RGD:1598411 , RGD:2306694
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10rb
interleukin 10 receptor subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr11:30,646,494...30,668,081
Ensembl chr11:30,652,096...30,668,074
G
Il12rb1
interleukin 12 receptor subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
G
Il17a
interleukin 17A
IEP ISO
protein, mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism protein:increased expression:brain
CTD RGD
PMID:15829914 PMID:16305645 PMID:16305645
RGD:4846398 , RGD:4846398
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il17ra
interleukin 17 receptor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
G
Il18
interleukin 18
IEP ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:11807395
RGD:4889510
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9236716 PMID:15737438 PMID:15756928 PMID:17394460
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9236716
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914 PMID:17394460
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
IEP
mRNA:increased expression:brain, astrocyte
RGD
PMID:15469886
RGD:1627568
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Irak1
interleukin-1 receptor-associated kinase 1
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:21925238
RGD:7495802
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Irak4
interleukin-1 receptor-associated kinase 4
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:21925238
RGD:7495802
NCBI chr 7:125,682,502...125,708,294
Ensembl chr 7:125,682,488...125,717,837
G
Itgam
integrin subunit alpha M
IEP
associated with Hypotension;protein:increased expression:pyramidal layer of CA1 (rat)
RGD
PMID:19019197
RGD:329853772
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kcnk10
potassium two pore domain channel subfamily K member 10
IEP
mRNA, protein:increased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:15652517
RGD:9831167
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
G
Kcnk2
potassium two pore domain channel subfamily K member 2
IEP
mRNA:increased expression:hippocampus (rat)
RGD
PMID:14741413
RGD:9831127
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kdr
kinase insert domain receptor
IMP
RGD
PMID:18951929
RGD:5684407
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Lgals3
galectin 3
IEP
RGD
PMID:10931529
RGD:9685227
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lif
LIF, interleukin 6 family cytokine
IEP
mRNA:increased expression:brain
RGD
PMID:20221422
RGD:2326053
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lonp1
lon peptidase 1, mitochondrial
IDA
RGD
PMID:12082077
RGD:633879
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Map2
microtubule-associated protein 2
IEP
protein:increased expression:serum
RGD
PMID:21948028
RGD:6483082
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Map2k1
mitogen activated protein kinase kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17901229 PMID:10536014
RGD:1582169
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Map3k7
mitogen activated protein kinase kinase kinase 7
treatment
ISO
RGD
PMID:21475303
RGD:155882442
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17901229 PMID:15669185
RGD:1582281
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
IDA
RGD
PMID:15797868
RGD:1582325
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapt
microtubule-associated protein tau
IDA
protein:increased phosphorylation
RGD
PMID:15353210
RGD:1599927
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mdh2
malate dehydrogenase 2
IDA
RGD
PMID:6282622
RGD:1582465
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
G
Mdk
midkine
ISO
RGD
PMID:12127679
RGD:1582476
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
G
Mir223
microRNA 223
treatment
IMP
RGD
PMID:31791013
RGD:26884340
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mmp13
matrix metallopeptidase 13
IDA
RGD
PMID:16112096
RGD:1582554
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp14
matrix metallopeptidase 14
IEP
RGD
PMID:15963646
RGD:1582577
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp2
matrix metallopeptidase 2
IEP
RGD
PMID:15963646
RGD:1582577
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15060315 PMID:16846501
RGD:1582611
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19417757
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Msi1
musashi RNA-binding protein 1
IEP
RGD
PMID:12205668
RGD:633285
NCBI chr12:41,158,301...41,251,134
Ensembl chr12:41,158,599...41,191,076
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15534175
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Naip6
NLR family, apoptosis inhibitory protein 6
IEP
protein:increased expression:thalamus (rat)
RGD
PMID:9288726
RGD:2317254
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
G
Nes
nestin
IEP
protein:increased expression:hippocampus
RGD
PMID:17697621
RGD:1642071
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nfkb1
nuclear factor kappa B subunit 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18628779
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18628779
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos1
nitric oxide synthase 1
IMP IEP
protein:decreased expression:hippocampus
RGD
PMID:17451676 PMID:21718970
RGD:1642142 , RGD:6480433
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9778187 PMID:17394460
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
IDA IMP
RGD
PMID:21212863 PMID:17600658
RGD:4891961 , RGD:2292134
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox4
NADPH oxidase 4
ISO
mRNA, protein:increased expression:cerebral cortex (human)
RGD
PMID:15802177
RGD:1580980
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Nppa
natriuretic peptide A
no_association
ISO
RGD
PMID:11706124
RGD:1626244
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nptxr
neuronal pentraxin receptor
IEP
mRNA:decreased expression:neocortex
RGD
PMID:12242102
RGD:1642302
NCBI chr 7:111,336,660...111,354,737
Ensembl chr 7:111,336,664...111,354,802
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
IEP
protein:decreased expression:brain cortex
RGD
PMID:17344647
RGD:4892115
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Oaz1
ornithine decarboxylase antizyme 1
IEP
mRNA:altered expression:cerebral cortex (rat)
RGD
PMID:19531214
RGD:401851038
NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:8,883,851...8,886,310
G
Oprm1
opioid receptor, mu 1
IEP
RGD
PMID:16176345
RGD:2316630
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Pak1
p21 (RAC1) activated kinase 1
IEP
protein:increased expression:brain
RGD
PMID:17997827
RGD:2299171
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17640816
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pcna
proliferating cell nuclear antigen
IEP
protein:increased expression:brain
RGD
PMID:12099899
RGD:729592
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pgf
placental growth factor
ISO
RGD
PMID:16901914
RGD:6483783
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Pla2g4a
phospholipase A2 group 4A
IEP
mRNA:increased expression:hippocampus
RGD
PMID:15306117
RGD:1642465
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Plat
plasminogen activator, tissue type
no_association
ISO
DNA:polymorphism:-7351C>T (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:7477192 PMID:9259745 PMID:9400355 PMID:9479658 PMID:9566367 PMID:9633741 PMID:10572812 PMID:11108748 PMID:11940547 PMID:12221155 PMID:12511774 PMID:14986460 PMID:15017018 PMID:15087567 PMID:16126134 PMID:16763187 PMID:16809570 PMID:17086147 PMID:17525387 PMID:17903870 PMID:20123226 PMID:20212195 PMID:20488584 PMID:20536612 PMID:21037505 PMID:23876515 PMID:16179568 More...
RGD:1580879
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9731615 PMID:10472989 PMID:10512912 PMID:17927297
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Ppbp
pro-platelet basic protein
ISO
RGD
PMID:26307429
RGD:11553187
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
G
Ppid
peptidylprolyl isomerase D
ISO
RGD
PMID:16103352
RGD:1580699
NCBI chr 2:164,727,803...164,740,168
Ensembl chr 2:164,727,779...164,740,221
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
IEP
protein:increased expression:cerebral cortex, caudate nucleus (rat)
RGD
PMID:15713259
RGD:9999408
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
IEP
protein:decreased expression:hippocampus, cerebral cortex, nucleus
RGD
PMID:12150772
RGD:7327190
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
IEP
protein:decreased expression:hippocampus, cerebral cortex, cytosol, nucleus
RGD
PMID:12150772
RGD:7327190
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
G
Prkca
protein kinase C, alpha
IEP
associated with Subarachnoid Hemorrhage;protein:increased phosphorylation:cerebral artery
RGD
PMID:18032736
RGD:2293301
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkcd
protein kinase C, delta
IMP
RGD
PMID:17350602
RGD:1642524
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Proz
protein Z, vitamin K-dependent plasma glycoprotein
ISO
RGD
PMID:14671240
RGD:1358564
NCBI chr16:76,450,013...76,463,558
Ensembl chr16:76,450,013...76,463,480
G
Ptgis
prostaglandin I2 synthase
IDA
RGD
PMID:16094316
RGD:8693629
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:microglia, macrophage
RGD
PMID:11740205 PMID:10867793
RGD:5688240 , RGD:5688247
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO IDA
protein:increased expression:hippocampus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15737438 PMID:17394460 PMID:17564305 PMID:19417757 PMID:21718970 PMID:11158633 PMID:12535784 More...
RGD:6480433 , RGD:5688292 , RGD:1581286
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2b
protein tyrosine kinase 2 beta
IDA
protein:increased tyrosine phosphorylation:cerebral cortex
RGD
PMID:10964954
RGD:1642647
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18628779
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ret
ret proto-oncogene
IEP
protein:increased expression:cerebral cortex
RGD
PMID:10407114
RGD:6218981
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
S100b
S100 calcium binding protein B
IEP
protein:increased expression:serum
RGD
PMID:21695352
RGD:5508764
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Scn5a
sodium voltage-gated channel alpha subunit 5
IEP
RGD
PMID:19471098
RGD:6484225
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
G
Sele
selectin E
ISO
associated with Hypertension CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17394460 PMID:19107136
RGD:2313600
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:27108052
RGD:11073613
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Slc11a2
solute carrier family 11 member 2
IEP
protein:increased expression:brain
RGD
PMID:21325818
RGD:5688411
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc29a1
solute carrier family 29 member 1
IMP
RGD
PMID:15829178
RGD:2316942
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc6a1
solute carrier family 6 member 1
IMP
RGD
PMID:15084665
RGD:1643209
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
G
Slc8a1
solute carrier family 8 member A1
IEP IMP
protein:increased expression:brain mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:17662498 PMID:22036625 PMID:12377375
RGD:1642717 , RGD:6771236 , RGD:727449
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc8a2
solute carrier family 8 member A2
IEP
RGD
PMID:16107787
RGD:2316979
NCBI chr 1:76,816,583...76,852,928
Ensembl chr 1:76,808,725...76,847,072
G
Slc8a3
solute carrier family 8 member A3
IEP
RGD
PMID:16107787
RGD:2316979
NCBI chr 6:100,874,359...101,007,989
Ensembl chr 6:100,874,369...101,007,508
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11756504
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15060315 PMID:17901229 PMID:19429140 PMID:10212301
RGD:1625695
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:10833313
RGD:1580852
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
IDA
RGD
PMID:26442853
RGD:155630597
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IDA
RGD
PMID:15854740
RGD:1581411
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tek
TEK receptor tyrosine kinase
IEP
RGD
PMID:11919509
RGD:634324
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Tgfb1
transforming growth factor, beta 1
IEP
mRNA:increased expression:brain
RGD
PMID:14997937
RGD:2302105
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Th
tyrosine hydroxylase
IEP
protein:decreased expression:solitary tract nucleus, medulla oblongata, locus coeruleus (rat)
RGD
PMID:18356740
RGD:5129691
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tjp1
tight junction protein 1
IEP
protein:decreased expression:brain
RGD
PMID:19712057
RGD:2325131
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr4
toll-like receptor 4
no_association
ISO
DNA:polymorphisms: :p.N299G, p.T399I (human)
RGD
PMID:15258789
RGD:1580737
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15756928
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:16442237
RGD:1624184
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19095966
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ttr
transthyretin
IEP
RGD
PMID:15469881
RGD:1580523
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17052689
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Vip
vasoactive intestinal peptide
IDA
RGD
PMID:18158987
RGD:5685617
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
IEP
protein:increased expression:cerebrospinal fluid
RGD
PMID:15902199
RGD:2306031
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Acvr2b
activin A receptor type 2B
severity
ISO
mRNA, protein:increased expression:umbilical cord blood (human)
RGD
PMID:27957679
RGD:329849106
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Ada
adenosine deaminase
IEP
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adk
adenosine kinase
IEP
protein:decreased expression:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Adnp
activity-dependent neuroprotector homeobox
IDA
RGD
PMID:16938277
RGD:2312775
NCBI chr 3:156,886,921...156,921,500
Ensembl chr 3:156,891,381...156,917,312
G
Adora1
adenosine A1 receptor
IEP
protein:decreased expression:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Agtr2
angiotensin II receptor, type 2
IMP
RGD
PMID:22569153
RGD:6903872
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:right cerebral hemisphere (rat)
RGD
PMID:19447505
RGD:2313021
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP
protein:increased expression:nucleus:
RGD
PMID:12871572 PMID:28108258
RGD:10053564 , RGD:13524865
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:21189961 PMID:24089674 PMID:29635023
RGD:10054502 , RGD:155882465 , RGD:13782292
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcan
brevican
IEP
RGD
PMID:15817274
RGD:14392799
NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:21189961 PMID:24089674 PMID:29635023
RGD:10054502 , RGD:155882465 , RGD:13782292
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
IDA
RGD
PMID:24195677
RGD:10053669
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Becn1
beclin 1
IEP
protein:increased expression:cerebral cortex protein:increased expression:brain
RGD
PMID:22449108 PMID:25919564
RGD:6483050 , RGD:11558017
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bmal1
basic helix-loop-helix ARNT like 1
IEP
protein:increased expression:pineal gland
RGD
PMID:23336172
RGD:10043348
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
G
Bmp4
bone morphogenetic protein 4
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:23236544
RGD:8699519
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Casp1
caspase 1
IEP
RGD
PMID:23046993
RGD:13782359
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
IDA
protein:increased activity:cerebral cortex, hippocampus
RGD
PMID:18603371
RGD:2311455
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
treatment
IDA IEP
protein:increased activity:cerebral cortex, hippocampus
RGD
PMID:18603371 PMID:24089674 PMID:23046993 PMID:29635023 PMID:27216999 PMID:21189961 More...
RGD:2311455 , RGD:155882465 , RGD:13782359 , RGD:13782292 , RGD:13782279 , RGD:10054502
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:29635023 PMID:23046993
RGD:13782292 , RGD:13782359
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:23046993 PMID:24089674
RGD:13782359 , RGD:155882465
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
IEP
RGD
PMID:10318818
RGD:5683321
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
treatment
ISO
RGD
PMID:21978706
RGD:9068474
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
IEP
protein:increased expression:forebrain (rat)
RGD
PMID:9270493
RGD:8549543
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
IEP
mRNA, protein:increased expression:brain
RGD
PMID:18095591
RGD:4144890
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:cerebral hemisphere (rat)
RGD
PMID:16516309
RGD:4890442
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
treatment
IMP
RGD
PMID:25665755
RGD:13782373
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Clock
clock circadian regulator
IEP
protein:increased expression:pineal gland
RGD
PMID:23336172
RGD:10043348
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
IEP
RGD
PMID:19747899
RGD:6483337
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Crp
C-reactive protein
ISO
RGD
PMID:20220110
RGD:9585994
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cs
citrate synthase
treatment
IDA
RGD
PMID:15132986 PMID:15569775
RGD:243048479 , RGD:243048481
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Csf1r
colony stimulating factor 1 receptor
exacerbates
IMP IEP
protein:increased expression:right cerebral hemisphere, astrocyte, neuron (rat)
RGD
PMID:32522286 PMID:33101590
RGD:151665765 , RGD:151665766
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Cxcr3
C-X-C motif chemokine receptor 3
IEP
mRNA:increased expression:brain
RGD
PMID:17549754
RGD:2311381
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Daxx
death-domain associated protein
IMP
RGD
PMID:21843499
RGD:9587791
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Dnmt3a
DNA methyltransferase 3 alpha
IEP
protein:decreased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Egr1
early growth response 1
IEP
mRNA:increased expression:forebrain (rat)
RGD
PMID:7684483
RGD:2289081
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
IDA
RGD
PMID:8092984
RGD:10395352
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Epha4
Eph receptor A4
IEP
protein:increased expression:brain
RGD
PMID:21736568
RGD:5688765
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
G
Epo
erythropoietin
treatment
IEP ISO
RGD
PMID:24034924 PMID:22156696
RGD:10400911 , RGD:10401072
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12694393
RGD:632668
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Fadd
Fas associated via death domain
treatment
IEP
RGD
PMID:29635023
RGD:13782292
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
IEP
RGD
PMID:21843499
RGD:9587791
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
protein:decreased expression:hippocampus
RGD
PMID:25262910
RGD:405650622
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxo3
forkhead box O3
IEP
protein:increased expression:cerebral cortex,nucleus:
RGD
PMID:24229603
RGD:10402203
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Fst
follistatin
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:10415398
RGD:329322882
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
G
Ghr
growth hormone receptor
IEP
protein:increased expression:brain
RGD
PMID:19524466
RGD:2315620
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Gsn
gelsolin
severity
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:29466895
RGD:329333029
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
IEP
mRNA:decreased expression:hippocampus,cortex:
RGD
PMID:19892002
RGD:9686395
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
G
Hdac3
histone deacetylase 3
IEP
protein:decreased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP ISO IDA
protein:increased expression:brain (rat) mRNA, protein:increased expression:brain,kidney (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23694759 PMID:18210138 PMID:31784544 PMID:19595151
RGD:9068873 , RGD:155882534 , RGD:9068901
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:25447631
RGD:10766440
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
IEP
RGD
PMID:22526757
RGD:7257595
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
IMP
RGD
PMID:16397188
RGD:1626654
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Igf1
insulin-like growth factor 1
treatment
ISO IDA IEP
RGD
PMID:11672597 PMID:23694759 PMID:19766709
RGD:8549456 , RGD:12904932 , RGD:10046049
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf2
insulin-like growth factor 2
disease_progression
ISO
RGD
PMID:16787587
RGD:5510005
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igfbp3
insulin-like growth factor binding protein 3
IEP
RGD
PMID:10709766
RGD:10402756
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Il1b
interleukin 1 beta
IEP
protein:increased expression:brain (rat)
RGD
PMID:23110519
RGD:7204438
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
severity
ISO
DNA:polymorphism: :174G>C(human)
RGD
PMID:22117975
RGD:12792241
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhba
inhibin subunit beta A
severity treatment
IEP ISO
mRNA:increased expression:brain (rat) mRNA, protein:increased expression:umbilical cord blood (human) human construct in rat model
RGD
PMID:10415398 PMID:27957679 PMID:10415398
RGD:329322882 , RGD:329849106 , RGD:329322882
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Irak1
interleukin-1 receptor-associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21925238
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Irak4
interleukin-1 receptor-associated kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21925238
NCBI chr 7:125,682,502...125,708,294
Ensembl chr 7:125,682,488...125,717,837
G
Ireb2
iron responsive element binding protein 2
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:27602087
RGD:12903962
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
G
Kdr
kinase insert domain receptor
IMP
RGD
PMID:21277350
RGD:5684383
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
IEP
RGD
PMID:25919564
RGD:11558017
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map2
microtubule-associated protein 2
IDA
RGD
PMID:21300124
RGD:6483088
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
IEP
RGD
PMID:21843499
RGD:9587791
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates
ISO IEP
protein:increased expression:brain (rat)
RGD
PMID:29138854 PMID:32734729
RGD:155804273 , RGD:155804275
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapt
microtubule-associated protein tau
treatment
IDA
RGD
PMID:25665755
RGD:13782373
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mbd2
methyl-CpG binding domain protein 2
IEP
protein:increased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mbp
myelin basic protein
IEP
protein:decreased expression:white matter:
RGD
PMID:23715956
RGD:7327196
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mir140
microRNA 140
severity
ISO
miRNA:decreased expression:blood serum (human)
RGD
PMID:34331407
RGD:329347831
NCBI chr19:35,465,577...35,465,675
Ensembl chr19:35,465,577...35,465,675
G
Mir17
microRNA 17
ISO
RGD
PMID:35085690
RGD:329349305
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
G
Mir210
microRNA 210
treatment disease_progression
IMP ISO
miRNA:decreased expression:blood serum (human) associated with Brain Injuries;miRNA:increased expression:brain, cerebral hemisphere (human)
RGD
PMID:26875527 PMID:24089674 PMID:29568675 PMID:33402183
RGD:11572290 , RGD:155882465 , RGD:155598592 , RGD:155582222
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mmp3
matrix metallopeptidase 3
treatment
IEP
RGD
PMID:21038694
RGD:8694100
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mpo
myeloperoxidase
IEP
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Naglu
N-acetyl-alpha-glucosaminidase
IEP
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr10:86,001,545...86,009,049
Ensembl chr10:86,001,566...86,008,972
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23694759
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nrf1
nuclear respiratory factor 1
IEP
mRNA, protein:increase expression:cerebral cortex
RGD
PMID:18723421
RGD:2302400
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
IEP
mRNA:increased expression:brain
RGD
PMID:19633950
RGD:5684358
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Pdgfb
platelet derived growth factor subunit B
IEP
RGD
PMID:10215166
RGD:10449494
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Plat
plasminogen activator, tissue type
onset
IEP
RGD
PMID:18467699
RGD:6483831
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
IDA IEP
mRNA, protein:increased expression, increased activity:hippocampus (rat)
RGD
PMID:19587273 PMID:18467699
RGD:2316117 , RGD:6483831
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
IEP
RGD
PMID:23153068
RGD:13515077
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
treatment
IMP
RGD
PMID:30485360
RGD:39938998
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Prkdcem1Sage
protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage
treatment
IMP
RGD
PMID:30485360
RGD:39938998
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
IEP
STEP33;protein:increased expression:forebrain (rat)
RGD
PMID:10537057
RGD:9835021
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
IEP
RGD
PMID:16041802
RGD:9590116
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
Rnf146
ring finger protein 146
IEP
RGD
PMID:28108258
RGD:13524865
NCBI chr 1:28,458,864...28,475,758
Ensembl chr 1:28,458,887...28,475,923
G
Robo1
roundabout guidance receptor 1
exacerbates
IMP
RGD
PMID:31356825
RGD:242905191
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
G
S100b
S100 calcium binding protein B
severity
ISO
associated with Asphyxia Neonatorum;protein:increased expression:urine protein:increased expression:blood serum (human)
RGD
PMID:14707571 PMID:29568675
RGD:5508819 , RGD:155598592
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Serpine1
serpin family E member 1
ISO
RGD
PMID:19587273
RGD:2316117
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Slc9a1
solute carrier family 9 member A1
IMP
RGD
PMID:20883671
RGD:6771331
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Slit2
slit guidance ligand 2
treatment
IEP
RGD
PMID:31356825
RGD:242905191
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Spi1
Spi-1 proto-oncogene
IEP
protein:increased expression:CA1 field of hippocampus
RGD
PMID:10713349
RGD:9586724
NCBI chr 3:77,059,744...77,093,730
Ensembl chr 3:77,073,012...77,092,393
G
Srgap1
SLIT-ROBO Rho GTPase activating protein 1
exacerbates
IMP
RGD
PMID:31356825
RGD:242905191
NCBI chr 7:57,329,532...57,594,681
Ensembl chr 7:57,329,532...57,596,196
G
Tert
telomerase reverse transcriptase
treatment
IDA
RGD
PMID:21940960
RGD:11038672
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tf
transferrin
treatment
ISO
RGD
PMID:22736466
RGD:7244383
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tfam
transcription factor A, mitochondrial
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:18723421
RGD:2302400
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:28139935
RGD:15090829
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
IEP
mRNA:increased expression:glomerular podocytes (rat)
RGD
PMID:31784544
RGD:155882534
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23694759
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Zeb2
zinc finger E-box binding homeobox 2
IEP IMP
mRNA:increased expression:glomerular podocytes (rat)
RGD
PMID:31784544 PMID:34852714
RGD:155882534 , RGD:155882542
NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157
G
Adipoq
adiponectin, C1Q and collagen domain containing
IDA
RGD
PMID:19362080
RGD:5686830
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adk
adenosine kinase
ISO IMP
RGD
PMID:16685255 PMID:9731623
RGD:6482657 , RGD:6482667
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Adm
adrenomedullin
treatment
ISO
RGD
PMID:21695352
RGD:5508764
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adnp
activity-dependent neuroprotector homeobox
IDA
RGD
PMID:11935065
RGD:1358226
NCBI chr 3:156,886,921...156,921,500
Ensembl chr 3:156,891,381...156,917,312
G
Aif1
allograft inflammatory factor 1
IEP ISO
protein:increased expression:brain subventricular zone (rat) protein:increased expression:brain white matter (human)
RGD
PMID:19053043 PMID:10683518
RGD:2313025 , RGD:2313026
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Aldh2
aldehyde dehydrogenase 2 family member
susceptibility
ISO
RGD
PMID:17388993
RGD:1601161
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
associated with Metabolic Syndrome X; DNA:polymorphism:g.162A>C rs4769055 (human)
RGD
PMID:18506375
RGD:2311309
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Arrb2
arrestin, beta 2
IEP
protein:increased expression:spleen
RGD
PMID:29636059
RGD:401938621
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
G
Becn1
beclin 1
IEP
protein:increased expression:brain
RGD
PMID:22227058
RGD:6483057
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
G
Calcrl
calcitonin receptor like receptor
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
G
Cd8a
CD8 subunit alpha
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
G
Cfh
complement factor H
treatment
ISO
RGD
PMID:21695352
RGD:5508764
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Cort
cortistatin
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 5:159,560,591...159,562,032
G
Ctsb
cathepsin B
IEP
protein:increased expression:cerebral cortical segment, cytoplasm (rat)
RGD
PMID:19941836
RGD:2315502
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Cxcl10
C-X-C motif chemokine ligand 10
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cybb
cytochrome b-245 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19417757
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp11b1
cytochrome P450, family 11, subfamily b, polypeptide 1
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 7:106,772,597...106,780,536
Ensembl chr 7:106,718,274...106,779,278
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
DNA:variants:CDS:multiple (human)
RGD
PMID:36762557
RGD:401901151
NCBI chr 1:168,749,302...168,798,079
Ensembl chr 1:168,751,038...168,797,759
G
Dcx
doublecortin
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
G
Ece1
endothelin converting enzyme 1
ISO
RGD
PMID:15485550
RGD:1580908
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17524524
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Gpnmb
glycoprotein nmb
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr17
G protein-coupled receptor 17
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18974869
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Gzmb
granzyme B
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
Hgf
hepatocyte growth factor
treatment
IDA
RGD
PMID:16421510
RGD:8548626
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
exacerbates
IMP
RGD
PMID:30052311
RGD:155663378
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
IMP
RGD
PMID:19944723
RGD:2316741
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hnmt
histamine N-methyltransferase
severity
IMP
RGD
PMID:21131122 PMID:16330002
RGD:5509772 , RGD:5509773
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Htr2b
5-hydroxytryptamine receptor 2B
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Icam1
intercellular adhesion molecule 1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:serum
RGD
PMID:18692933
RGD:2313474
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Igf2
insulin-like growth factor 2
IEP
mRNA, protein:increased expression:brain
RGD
PMID:7770004
RGD:5509999
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Il15
interleukin 15
ISO
associated with Hypertension;protein:increased expression:serum
RGD
PMID:16109314
RGD:1626610
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:17678971
RGD:1626644
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Kcnk6
potassium two pore domain channel subfamily K member 6
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 1:84,525,613...84,533,948
Ensembl chr 1:84,525,590...84,534,677
G
Mdk
midkine
IDA
RGD
PMID:15450683
RGD:1582478
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
G
Meis2
Meis homeobox 2
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr 3:102,742,904...102,944,833
Ensembl chr 3:102,742,900...102,949,696
G
Mgp
matrix Gla protein
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mir223
microRNA 223
IEP
RNA:increased expression:brain,blood
RGD
PMID:31342956
RGD:25824952
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mmp14
matrix metallopeptidase 14
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp8
matrix metallopeptidase 8
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:16599837
RGD:1582617
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Msi1
musashi RNA-binding protein 1
IEP
RGD
PMID:15250238
RGD:1582664
NCBI chr12:41,158,301...41,251,134
Ensembl chr12:41,158,599...41,191,076
G
Nes
nestin
IEP
associated with Hypertension
RGD
PMID:16321245
RGD:1642069
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Parg
poly (ADP-ribose) glycohydrolase
IMP
associated with Reperfusion Injury
RGD
PMID:12834903
RGD:2316742
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
G
Pbx1
PBX homeobox 1
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
G
Pdgfb
platelet derived growth factor subunit B
IMP
RGD
PMID:14980813
RGD:1581758
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16190367
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Prcp
prolylcarboxypeptidase
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530
G
Rbfox3
RNA binding fox-1 homolog 3
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
G
RT1-Ba
RT1 class II, locus Ba
ISO
DNA:polymorphisms (human)
RGD
PMID:11798899
RGD:5147807
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
Scn7a
sodium voltage-gated channel alpha subunit 7
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 3:51,335,841...51,438,308
Ensembl chr 3:51,335,841...51,438,256
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22878646
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Tbxas1
thromboxane A synthase 1
IDA
RGD
PMID:14650360
RGD:1601455
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
G
Tnf
tumor necrosis factor
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tpcn2
two pore segment channel 2
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 1:200,416,538...200,446,252
Ensembl chr 1:200,416,540...200,446,236
G
Htra1
HtrA serine peptidase 1
ISO
ClinVar Annotator: match by term: CARASIL | ClinVar Annotator: match by term: CARASIL syndrome | ClinVar Annotator: match by term: Cerebrovascular disease with thin skin, alopecia, and disc disease | ClinVar Annotator: match by term: HTRA1-related cerebral small vessel disease
OMIM ClinVar
PMID:11889251 PMID:18316707 PMID:19387015 PMID:20437615 PMID:21115960 PMID:21482952 PMID:22900900 PMID:23963851 PMID:24500651 PMID:24535794 PMID:25506911 PMID:25741868 PMID:25770224 PMID:25772074 PMID:25957642 PMID:26063658 PMID:26467025 PMID:27164673 PMID:27353043 PMID:28492532 PMID:28782182 PMID:29561953 PMID:29895533 PMID:30859180 PMID:31316458 PMID:32042911 PMID:32101834 PMID:32581362 PMID:33268848 PMID:34220097 PMID:35307828 PMID:35606766 PMID:36047879 PMID:36253578 PMID:36261288 PMID:36380532 More...
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Pura
purine rich element binding protein A
ISO
ClinVar Annotator: match by term: Cerebrovascular disease with thin skin, alopecia, and disc disease
ClinVar
PMID:24500651 PMID:27148565
NCBI chr18:27,885,071...27,905,509
Ensembl chr18:27,884,556...27,905,513
G
A2m
alpha-2-macroglobulin
disease_progression
ISO
RGD
PMID:28266892
RGD:13702087
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Ace
angiotensin I converting enzyme
ISO
DNA:deletion:intron:IVS16+1464-1751del (human) ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
ClinVar RGD
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:11596779 More...
RGD:11038922
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adora1
adenosine A1 receptor
IDA
RGD
PMID:17067559
RGD:1625229
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
ISO
protein:increased expression:plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Agxt2
alanine-glyoxylate aminotransferase 2
onset
ISO
DNA:missense mutation:cds:V498L (rs16899974) (human)
RGD
PMID:26984639
RGD:329961314
NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926
G
Ahsp
alpha hemoglobin stabilizing protein
ISO
mRNA:increased expression:venous blood (human)
RGD
PMID:29284304
RGD:329961296
NCBI chr 1:182,879,901...182,885,508
Ensembl chr 1:182,880,076...182,885,506
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
susceptibility
ISO
OMIM
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Ang
angiogenin
severity
ISO
protein:increased expression:serum
RGD
PMID:17823536
RGD:6892714
NCBI chr15:24,312,711...24,323,361
G
Anxa1
annexin A1
treatment
IEP
associated with Ischemic Attack, Transient
RGD
PMID:22617647
RGD:7483559
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Apoa5
apolipoprotein A5
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism: :-1131T>C (human)
RGD
PMID:19107359
RGD:2313314
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apob
apolipoprotein B
ISO
protein:increased expression:serum
RGD
PMID:2352345
RGD:2313973
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:polymorphism: :3932T>C (human)
RGD
PMID:17016617
RGD:1601237
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Bhmt
betaine-homocysteine S-methyltransferase
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Brinp3
BMP/retinoic acid inducible neural specific 3
ISO
associated with diabetes mellitus;mRNA:protein:increased expression:blood mononuclear cell:
RGD
PMID:26717922
RGD:14398486
NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770
G
Cbs
cystathionine beta synthase
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccr5
C-C motif chemokine receptor 5
ISO
RGD
PMID:23602964
RGD:8552262
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd36
CD36 molecule
ISO
associated with Hyperlipidemias
RGD
PMID:22718544
RGD:6893487
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Ephx2
epoxide hydrolase 2
IDA
RGD
PMID:16306811
RGD:1580986
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
F2
coagulation factor II, thrombin
susceptibility
ISO
ClinVar Annotator: match by term: Ischemic stroke | ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
ClinVar OMIM
PMID:2222810 PMID:2429850 PMID:2825773 PMID:6305407 PMID:8696333 PMID:8896550 PMID:8916933 PMID:9106528 PMID:9292507 PMID:9462220 PMID:9493607 PMID:9531249 PMID:9569177 PMID:9694698 PMID:9869612 PMID:10027711 PMID:10233438 PMID:10233439 PMID:10336270 PMID:10348710 PMID:10348711 PMID:10348712 PMID:10406905 PMID:10477778 PMID:10544935 PMID:11358905 PMID:11443298 PMID:11506076 PMID:11796466 PMID:11874997 PMID:11904676 PMID:15059842 PMID:15534175 PMID:16493002 PMID:16606808 PMID:19159930 PMID:19289024 PMID:19531787 PMID:19554541 PMID:19560233 PMID:19652888 PMID:20301327 PMID:21243428 PMID:21349849 PMID:23429074 PMID:24033266 PMID:25741868 PMID:27031503 PMID:28492532 PMID:28707429 PMID:30297698 PMID:34110897 PMID:34355501 More...
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F5
coagulation factor V
ISO
ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
ClinVar OMIM
PMID:7586244 PMID:7803250 PMID:7877648 PMID:7910348 PMID:7911872 PMID:7968118 PMID:8049422 PMID:8164730 PMID:8164741 PMID:8566967 PMID:8616100 PMID:8822583 PMID:9245936 PMID:9339109 PMID:9372726 PMID:9415695 PMID:9454741 PMID:9459326 PMID:9518910 PMID:9734642 PMID:10328130 PMID:10348711 PMID:10477778 PMID:10494770 PMID:10507841 PMID:10666427 PMID:11018168 PMID:11110695 PMID:11686338 PMID:12069454 PMID:12070000 PMID:12421138 PMID:14996674 PMID:15208046 PMID:15534175 PMID:15638861 PMID:15946211 PMID:16493002 PMID:16769590 PMID:16931580 PMID:19652888 PMID:20051284 PMID:21116184 PMID:21774968 PMID:22704462 PMID:22992668 PMID:23382263 PMID:23677252 PMID:23900608 PMID:24033266 PMID:25741868 PMID:25977387 PMID:26251307 PMID:26990548 PMID:27797270 PMID:28492532 PMID:28750087 PMID:34355501 More...
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
F7
coagulation factor VII
treatment
ISO
protein:increased expression, increased activity:plasma (human) human protein in a mouse model
RGD
PMID:14733777 PMID:21998055
RGD:11049518 , RGD:11049520
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Fbn1
fibrillin 1
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:7611299 PMID:8894692 PMID:9401003 PMID:9536098 PMID:10533071 PMID:10874320 PMID:11700157 PMID:12402346 PMID:12938084 PMID:14695540 PMID:16220557 PMID:16222657 PMID:16835936 PMID:17253931 PMID:17576681 PMID:17657824 PMID:17663468 PMID:19159394 PMID:19293843 PMID:21542060 PMID:24033266 PMID:24161884 PMID:25741868 PMID:26133393 PMID:28492532 PMID:29357934 PMID:31098894 PMID:37684520 More...
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
G
Folh1
folate hydrolase 1
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
G
Gch1
GTP cyclohydrolase 1
exacerbates treatment
ISO IMP
DNA:SNP:3' UTR:+243C>T (human) DNA:SNP, haplotype:rs841 (human)
RGD
PMID:21181356 PMID:16282548 PMID:21963893
RGD:329961322 , RGD:329961574 , RGD:329961572
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gp6
glycoprotein VI
ameliorates
ISO
RGD
PMID:34237320
RGD:401794450
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
G
Gpx3
glutathione peroxidase 3
susceptibility
ISO
DNA, protein:SNP,decreased expression:promoter,plasma:-861A>T (human) DNA:SNPs, haplotypes:promoter:rs8177412, rs870407, rs870406 (human) DNA:SNPs, haplotype:promoter:-942 A>C, -927 T>C, -861 A>T, -302 A>T, -284 T>A, -568 T>C, -518 T>C, -65 T>C (human)
RGD
PMID:25126700 PMID:20946167 PMID:17122425
RGD:401827128 , RGD:401827165 , RGD:401827163
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
severity
ISO
RGD
PMID:23723305
RGD:13792693
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grn
granulin precursor
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:18723524 PMID:25741868 PMID:28492532
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsn
gelsolin
severity
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:21481565
RGD:329337334
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
H19
H19 imprinted maternally expressed transcript
disease_progression susceptibility ameliorates
ISO
RNA:increased expression:blood plasma, plasma exosome (human) DNA:SNP::(rs217727) (human) DNA:SNPs,haplotypes: (rs217727,rs4929984) (human) associated with atherosclerosis
RGD
PMID:36453417 PMID:33541284 PMID:28203482 PMID:30778327 PMID:36453417
RGD:155882574 , RGD:156430336 , RGD:155900760 , RGD:155900761 , RGD:155882574
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
Hba-a2
hemoglobin alpha, adult chain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1634355
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
G
Hif1a
hypoxia inducible factor 1 subunit alpha
severity
ISO
protein:increased expression:blood serum (human)
RGD
PMID:34708885
RGD:155260326
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:23311871
RGD:10755574
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf1a
HNF1 homeobox A
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:28035729
RGD:329901837
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
G
Icam1
intercellular adhesion molecule 1
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:20083630
RGD:8547724
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifnb1
interferon beta 1
susceptibility no_association
ISO IDA
DNA:SNP,haplotype: rs9333358(human)
RGD
PMID:31810024 PMID:16514094
RGD:401851921 , RGD:401854228
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
treatment
IEP
RGD
PMID:20584315
RGD:8655991
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf8
interferon regulatory factor 8
exacerbates
ISO
RGD
PMID:24528256
RGD:329902074
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Itga9
integrin subunit alpha 9
susceptibility
ISO
DNA:SNPs,haplotype:rs189897,rs2212020(human)
RGD
PMID:21764681
RGD:13602007
NCBI chr 8:118,307,424...118,615,527
Ensembl chr 8:118,307,381...118,613,754
G
Itgam
integrin subunit alpha M
ISO
protein:increased expression:neutrophil (human)
RGD
PMID:31355307
RGD:329901831
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Kalrn
kalirin, RhoGEF kinase
susceptibility sexual_dimorphism
ISO
DNA:SNP:intron: (rs6438833) (human) DNA:SNPs, haplotypes:intron,cds: (rs7620580, rs1708303) (human)
RGD
PMID:25917671 PMID:28706949
RGD:11085239 , RGD:329956420
NCBI chr11:66,198,155...66,803,166
Ensembl chr11:66,198,173...66,797,610
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO
RGD
PMID:29037241
RGD:329969881
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Lipg
lipase G, endothelial type
susceptibility
ISO
DNA:polymorphism: :584C>T (human)
RGD
PMID:17016617
RGD:1601237
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lta
lymphotoxin alpha
ISO
RGD
PMID:14593215
RGD:1580416
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Map2
microtubule-associated protein 2
IDA
RGD
PMID:22444278
RGD:6483079
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IMP
RGD
PMID:23968852
RGD:10412642
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mir145
microRNA 145
ameliorates
ISO
miRNA:increased expression:blood (human)
RGD
PMID:22370881 PMID:26722607
RGD:155260291 , RGD:155260295
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir21
microRNA 21
IEP
RNA:increased expression:brain
RGD
PMID:20840605
RGD:41410884
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
severity treatment
ISO
miRNA:decreased expression:blood (human) miRNA:decreased expression:blood serum (human)
RGD
PMID:21622133 PMID:29111308 PMID:34708885
RGD:155260318 , RGD:155260331 , RGD:155260326
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir223
microRNA 223
treatment
IEP
RGD
PMID:28469772
RGD:35668865
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mir30a
microRNA 30a
treatment
IEP
RGD
PMID:28469772
RGD:35668865
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
G
Mir383
microRNA 383
treatment
IEP
RGD
PMID:28469772
RGD:35668865
NCBI chr16:54,040,340...54,040,413
Ensembl chr16:54,040,340...54,040,413
G
Mir494
microRNA 494
disease_progression
ISO
RGD
PMID:32239566
RGD:155883173
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16846501
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16846501
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt-cyb
mitochondrially encoded cytochrome b
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:transition:cds:g.677C>T (human)
RGD
PMID:10929044
RGD:1580590
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Myrf
myelin regulatory factor
ISO
DNA:SNP:exon:rs174535(human)
RGD
PMID:36193932
RGD:213230151
NCBI chr 1:206,854,175...206,886,276
Ensembl chr 1:206,854,175...206,886,157
G
Ndufa13
NADH:ubiquinone oxidoreductase subunit A13
IEP
protein:increased expression:brain, neuron, astrocyte:
RGD
PMID:17523870
RGD:401854233
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726
G
Nos3
nitric oxide synthase 3
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 PMID:28492532 More...
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Notch3
notch receptor 3
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:9388399 PMID:10371548 PMID:10802804 PMID:10854111 PMID:11102981 PMID:11755616 PMID:15364702 PMID:16009764 PMID:16193256 PMID:17729386 PMID:20301673 PMID:25623805 PMID:25741868 PMID:26308724 PMID:26467025 PMID:26843489 PMID:26912635 PMID:27206574 PMID:27890607 PMID:28492532 PMID:28710804 PMID:31915071 PMID:32277177 PMID:32457593 PMID:32581362 PMID:34335700 PMID:34691145 More...
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
G
Npy
neuropeptide Y
IEP ISO
protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11821007 PMID:17123484
RGD:10448931
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
susceptibility
ISO
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Park7
Parkinsonism associated deglycase
treatment
ISO
RGD
PMID:18003894 PMID:18003894
RGD:13462069 , RGD:13462069
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
G
Pdx1
pancreatic and duodenal homeobox 1
ISO
associated with Metabolic Syndrome; DNA:duplication:5' utr:-108 3G>4G (human)
RGD
PMID:18506375
RGD:2311309
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
G
Phactr1
phosphatase and actin regulator 1
ISO
DNA:SNP:intron: (rs12526453) (human)
RGD
PMID:23042660
RGD:401900685
NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831
G
Pla2g7
phospholipase A2 group VII
ISO
RGD
PMID:18201705
RGD:6482775
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:1579960 PMID:1899364 PMID:9183334 PMID:16148626 PMID:18195371 PMID:18544249 More...
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12133459 PMID:16773802
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
ISO
RGD
PMID:20138161
RGD:6483804
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Pon1
paraoxonase 1
susceptibility
ISO
DNA:missense mutation:cds:p.Q192R (human)
RGD
PMID:10729395
RGD:1580196
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Pon2
paraoxonase 2
susceptibility
ISO
DNA:SNPs,haplotypes: (rs11545941, rs6954345) (human)
RGD
PMID:20458436
RGD:401794454
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
G
Prkch
protein kinase C, eta
susceptibility
ISO
ClinVar Annotator: match by term: Cerebral infarction, susceptibility to | ClinVar Annotator: match by term: Ischemic stroke
ClinVar OMIM
PMID:12958323 PMID:17206144 PMID:25741868
NCBI chr 6:92,292,000...92,490,663
Ensembl chr 6:92,292,000...92,490,654
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33761690
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Pros1
protein S
ISO
DNA:missense mutation:exon:p.R355C (1063C>T) (human)
RGD
PMID:21172841
RGD:11250416
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Ptgis
prostaglandin I2 synthase
exacerbates treatment
ISO IMP
DNA:SNP, haplotype:3' utr: (rs5602) (human) DNA:SNPs:exon, 3' utr: (rs5629, rs5602) (human) DNA:repeat:promoter:g.-6(CCGCCAGCC)3-7 (human)
RGD
PMID:28478978 PMID:28108096 PMID:11130769 PMID:11997284
RGD:401901149 , RGD:401959400 , RGD:401901269 , RGD:401901194
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Rbp4
retinol binding protein 4
exacerbates severity
ISO
protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human) associated with diabetes mellitus; protein:increased expression:blood serum (human)
RGD
PMID:19846170 PMID:30030781 PMID:30038059
RGD:329845582 , RGD:329853305 , RGD:329845588
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
RT1-CE16
RT1 class I, locus CE16
susceptibility
ISO
DNA:polymorphism::HLA-A31:01 (human)
RGD
PMID:24767290
RGD:401827096
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphism,haplotype::HLA-B37:01 (human)
RGD
PMID:24767290
RGD:401827096
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:25702149
RGD:11075081
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
treatment
ISO
associated with Venous Thrombosis
RGD
PMID:10446335
RGD:8661653
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Slc6a1
solute carrier family 6 member 1
IEP
mRNA:increased expression:cerebral cortex, neuron
RGD
PMID:15349978
RGD:1643205
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
ISO
mRNA:increased expression:blood (human)
RGD
PMID:35041140
RGD:155598600
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
G
Tbxas1
thromboxane A synthase 1
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:19403042
RGD:11059536
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
G
Thbd
thrombomodulin
susceptibility
ISO
DNA:missense mutation:cds:p.A455V (human)
RGD
PMID:15574195
RGD:5685021
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tnf
tumor necrosis factor
treatment
ISO
RGD
PMID:16173529 PMID:29111308
RGD:1580315 , RGD:155260331
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
disease_progression
ISO
RGD
PMID:19895657
RGD:7205492
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tomm40
translocase of outer mitochondrial membrane 40
ISO
DNA:SNP: :rs2075650 (human)
RGD
PMID:26171154
RGD:13464126
NCBI chr 1:79,358,781...79,370,882
Ensembl chr 1:79,358,786...79,370,915
G
Tyms
thymidylate synthetase
susceptibility
ISO
DNA:SNPs,haplotypes: (rs502396,rs16430,rs8423)
RGD
PMID:20458436
RGD:401794454
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Vim
vimentin
IEP
RGD
PMID:18802758
RGD:6480442
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Aco1
aconitase 1
IEP
protein:decreased expression:hippocampus
RGD
PMID:22639386
RGD:11541085
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Apoe
apolipoprotein E
IEP
protein:increased expression:cerebral cortex, synapse
RGD
PMID:28620701
RGD:13703133
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
App
amyloid beta precursor protein
IEP
protein:increased expression:cerebral white matter:
RGD
PMID:11743996
RGD:10054250
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Bace1
beta-secretase 1
IEP
protein:increased expression:hippocampus
RGD
PMID:28683457
RGD:13782142
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Bnip3l
BCL2 interacting protein 3 like
IEP
mRNA:increased expression:hippocampus
RGD
PMID:24072673
RGD:10402542
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
Dag1
dystroglycan 1
IEP
RGD
PMID:21192954
RGD:11541061
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
G
Fth1
ferritin heavy chain 1
IEP
protein:increased expression:hippocampus
RGD
PMID:22639386
RGD:11541085
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Gstp1
glutathione S-transferase pi 1
treatment
IDA
RGD
PMID:16645134
RGD:10401930
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
IEP
RGD
PMID:24838625
RGD:9686415
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
G
Hcn2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
IEP
RGD
PMID:24838625
RGD:9686415
NCBI chr 7:9,969,801...9,988,839
Ensembl chr 7:9,970,368...9,988,841
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:hippocampus
RGD
PMID:24072673
RGD:10402542
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
protein:hyperphosphorylation:brain:
RGD
PMID:24371084
RGD:10412307
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mapk14
mitogen activated protein kinase 14
ISO
protein:hyperphosphorylation:corpus callosum, endothelial cell, astrocyte:
RGD
PMID:24371084
RGD:10412307
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mcm2
minichromosome maintenance complex component 2
IEP
protein:increased expression:dentate gyrus
RGD
PMID:17931356
RGD:10412049
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Nos3
nitric oxide synthase 3
IMP
RGD
PMID:15703700
RGD:13824977
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
ameliorates
IMP
RGD
PMID:24294978
RGD:329955573
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Tfrc
transferrin receptor
IEP
protein:increased expression:hippocampus
RGD
PMID:22639386
RGD:11541085
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Fshb
follicle stimulating hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17344003
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Abcc8
ATP binding cassette subfamily C member 8
treatment
IMP
RGD
PMID:23149556 PMID:24602692
RGD:12790979 , RGD:12791996
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
G
Ace
angiotensin I converting enzyme
treatment
IMP
RGD
PMID:24471927
RGD:11039026
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
IEP
mRNA, protein:increased expression:brain
RGD
PMID:24090950
RGD:9685436
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acvr1
activin A receptor type 1
ISO
RGD
PMID:33345977
RGD:329845521
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
G
Acvr2b
activin A receptor type 2B
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:33763412
RGD:329849104
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23437309
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
IEP ISO
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25446913 PMID:24211797
RGD:8696008
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
IEP
protein:increased expression:brain, serum
RGD
PMID:24090950
RGD:9685436
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP
protein:altered localization: :
RGD
PMID:15181376
RGD:10047403
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Ak1
adenylate kinase 1
IEP
protein:decreased expression:cerebral cortex (rat)
RGD
PMID:16468349
RGD:5508760
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Alb
albumin
treatment
ISO
RGD
PMID:22227456
RGD:11036100
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19309543
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Ap2b1
adaptor related protein complex 2 subunit beta 1
IEP
protein:increased degradation:brain
RGD
PMID:19240038
RGD:13461853
NCBI chr10:68,099,397...68,205,023
Ensembl chr10:68,099,547...68,205,013
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IEP
RGD
PMID:24012531
RGD:13703113
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apoe
apolipoprotein E
IDA
RGD
PMID:19623195
RGD:6903926
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
App
amyloid beta precursor protein
treatment
IEP
RGD
PMID:28963051
RGD:13782054
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Aqp4
aquaporin 4
treatment
IEP IMP
RGD
PMID:20815926 PMID:33127515
RGD:8695955 , RGD:155646130
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Arc
activity-regulated cytoskeleton-associated protein
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Atf3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
RGD
PMID:22200499 PMID:21891976
RGD:10053665 , RGD:10053704
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:23143152
RGD:10054501
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcan
brevican
IEP
RGD
PMID:15869933
RGD:9590118
NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:23143152
RGD:10054501
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP
RGD
PMID:20417695 PMID:28202057 PMID:35218623
RGD:4891138 , RGD:405878057 , RGD:401960864
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
treatment
IMP
RGD
PMID:22108007
RGD:11561900
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bnip3
BCL2 interacting protein 3
IEP
protein:increased expression:brain
RGD
PMID:17379825
RGD:9685412
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bnip3l
BCL2 interacting protein 3 like
IEP
RGD
PMID:15902200 PMID:21029239
RGD:2314138 , RGD:9068917
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
C1qtnf6
C1q and TNF related 6
ameliorates
IEP
RGD
PMID:35322553
RGD:242905190
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
G
C3
complement C3
IEP ISO
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23199288 PMID:22103620
RGD:7175514
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Calca
calcitonin-related polypeptide alpha
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
IEP
RGD
PMID:14688616
RGD:1358416
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Casp3
caspase 3
treatment
IDA IEP
RGD
PMID:21891976 PMID:26868427 PMID:23143152
RGD:10053704 , RGD:13782346 , RGD:10054501
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
IEP
RGD
PMID:26868427
RGD:13782346
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:26868427
RGD:13782346
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:12374626 PMID:23043544 PMID:25257527
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl7
C-C motif chemokine ligand 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Cd36
CD36 molecule
treatment
ISO
RGD
PMID:25216018
RGD:11041113
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd86
CD86 molecule
IEP
protein:increased expression:brain subventricular zone, microglial cell (rat)
RGD
PMID:19053043
RGD:2313025
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdk5
cyclin-dependent kinase 5
ISO
RGD
PMID:24920629
RGD:13782375
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cldn5
claudin 5
treatment
IEP
RGD
PMID:24842554
RGD:13204729
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Creb1
cAMP responsive element binding protein 1
treatment
IDA
RGD
PMID:35218623
RGD:401960864
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
IEP
protein:decreased expression:median eminence of hypothalamus (rat)
RGD
PMID:21741032
RGD:5490538
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Crp
C-reactive protein
ISO
RGD
PMID:15545914
RGD:9585995
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Crtc1
CREB regulated transcription coactivator 1
treatment
IEP
RGD
PMID:20417695
RGD:4891138
NCBI chr16:18,988,197...19,046,914
Ensembl chr16:18,988,250...19,043,381
G
Csf3
colony stimulating factor 3
treatment
ISO IEP
mRNA, protein:increased expression:brain:
RGD
PMID:19298757 PMID:15530654
RGD:11039420 , RGD:11039425
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:10825390
RGD:632989
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10825390
RGD:632989
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
IEP
RGD
PMID:23002367
RGD:14700877
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dicer1
dicer 1 ribonuclease III
IEP
mRNA:decreased expression:brain:
RGD
PMID:26294080
RGD:11553310
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
G
Dnmt1
DNA methyltransferase 1
ISO
RGD
PMID:11726790
RGD:9588643
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
IMP
RGD
PMID:23516428
RGD:9589049
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dynll1
dynein light chain LC8-type 1
IEP
RGD
PMID:9522364
RGD:13208524
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17197033
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Egr1
early growth response 1
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Egr4
early growth response 4
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
treatment
IDA IMP
RGD
PMID:23669639 PMID:19763736
RGD:10395346 , RGD:10755569
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:10700596
RGD:10450546
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Eng
endoglin
ISO
RGD
PMID:24876084
RGD:11041171
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Epcam
epithelial cell adhesion molecule
IEP
RGD
PMID:15950761
RGD:11038820
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Ephb2
Eph receptor B2
treatment
IEP ISO
mRNA,protein:increased expression: cortex, cerebral cortex subventricular zone
RGD
PMID:16321245 PMID:16321245
RGD:1642069 , RGD:1642069
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
G
Epn1
Epsin 1
IEP
protein:increased degradation:brain
RGD
PMID:19240038
RGD:13461853
NCBI chr 1:68,742,491...68,760,570
Ensembl chr 1:68,742,789...68,758,874
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:20833153 PMID:20547143
RGD:10400898 , RGD:10401066
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
IEP
RGD
PMID:9974119
RGD:10401103
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
G
F11
coagulation factor XI
ISO
RGD
PMID:16533887
RGD:11041786
NCBI chr16:46,987,988...47,009,015
Ensembl chr16:46,986,107...47,008,437
G
F12
coagulation factor XII
treatment
ISO
RGD
PMID:16533887 PMID:16533887
RGD:11041786 , RGD:11041786
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
F2
coagulation factor II, thrombin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29651748
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fadd
Fas associated via death domain
treatment
ISO IEP
RGD
PMID:18950622 PMID:23378241
RGD:11341807 , RGD:11344885
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fgf2
fibroblast growth factor 2
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgf21
fibroblast growth factor 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gabra6
gamma-aminobutyric acid type A receptor subunit alpha6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr10:26,810,411...26,825,768
Ensembl chr10:26,810,423...26,825,769
G
Gap43
growth associated protein 43
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
IDA
RGD
PMID:25882840
RGD:13792686
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gch1
GTP cyclohydrolase 1
treatment
IEP
RGD
PMID:24956890
RGD:401717568
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gdnf
glial cell derived neurotrophic factor
treatment
IMP IEP IDA
RGD
PMID:29497380 PMID:28202057 PMID:20468049 PMID:21347705
RGD:40925919 , RGD:405878057 , RGD:405866363 , RGD:405866359
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
G
Ghrl
ghrelin and obestatin prepropeptide
treatment
IDA
RGD
PMID:19352052
RGD:9850083
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Ghsr
growth hormone secretagogue receptor
IMP
RGD
PMID:19352052
RGD:9850083
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
G
Glul
glutamate-ammonia ligase
treatment
IEP
protein:increased expression:eye protein:increased expression:cerebrum, astrocyte
RGD
PMID:24518488 PMID:23595285 PMID:26024074 PMID:26093193
RGD:401794420 , RGD:401794586 , RGD:401794592 , RGD:401794587
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
treatment
IEP
RGD
PMID:26674869
RGD:11068571
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grn
granulin precursor
treatment
ISO
RGD
PMID:23972823
RGD:10401661
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Grpel1
GrpE-like 1, mitochondrial
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:12505684
RGD:632868
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:28440874
RGD:13792734
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
ameliorates
ISO
RGD
PMID:18234195 PMID:9927495
RGD:329333031 , RGD:329333033
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
H19
H19 imprinted maternally expressed transcript
ameliorates
IEP ISO IMP
RNA:increased expression:brain (rat) RNA:increased expression:brain (mouse)
RGD
PMID:28203482 PMID:28630232 PMID:35322553 PMID:31170091 PMID:32335212
RGD:155900760 , RGD:242905192 , RGD:242905190 , RGD:242905188 , RGD:156451661
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
Hamp
hepcidin antimicrobial peptide
IEP
mRNA, protein:increased expression:cerebral cortex, hippocampus, corpus striatum
RGD
PMID:21957487
RGD:11041635
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Has2
hyaluronan synthase 2
IEP
mRNA:increased expression:brain
RGD
PMID:11283406
RGD:9588631
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
G
Hdac2
histone deacetylase 2
exacerbates
ISO
RGD
PMID:32239566
RGD:155883173
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Hdac4
histone deacetylase 4
treatment
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:23480850
RGD:9681449
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hdac5
histone deacetylase 5
treatment
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:23480850
RGD:9681449
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
G
Hdac9
histone deacetylase 9
IEP
mRNA:increased expression:brain:
RGD
PMID:23480850
RGD:9681449
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
RGD
PMID:21029239
RGD:9068917
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:23480850
RGD:9681449
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP IDA ISO
RGD
PMID:24252362 PMID:23870531 PMID:20888632
RGD:10755587 , RGD:10755755 , RGD:10755588
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
IEP
RGD
PMID:22103620
RGD:7175514
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hspa4
heat shock protein family A (Hsp70) member 4
IMP ISO
rat gene in mouse model
RGD
PMID:17473852 PMID:21709150
RGD:5688754 , RGD:6218961
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Htra2
HtrA serine peptidase 2
IEP ISO
protein:increased expression:brain, cytosol (rat) protein:increased expression:brain, cytosol (mouse)
RGD
PMID:16978742 PMID:15306124
RGD:2314385 , RGD:5688372
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
G
Hvcn1
hydrogen voltage-gated channel 1
IMP
RGD
PMID:31250553
RGD:14985213
NCBI chr12:34,341,673...34,370,010
Ensembl chr12:34,335,190...34,370,141
G
Hvcn1em2Mcwi
hydrogen voltage-gated channel 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
IMP
RGD
PMID:31250553
RGD:14985213
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:16286924
RGD:10045955
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
ameliorates
ISO
RGD
PMID:28630232
RGD:242905192
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il11
interleukin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il13
interleukin 13
IEP
protein:increased expression:cerebral cortex
RGD
PMID:23028794
RGD:7204480
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il1b
interleukin 1 beta
ameliorates treatment
IEP ISO
protein:increased expression:cerebral cortex (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25257527 PMID:23028794 PMID:35322553 PMID:29498696 PMID:24916922
RGD:7204480 , RGD:242905190 , RGD:13792833 , RGD:10450594
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human gene in a rat model
RGD
PMID:7790404
RGD:8551708
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il22
interleukin 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Il4
interleukin 4
IEP
protein:increased expression:cerebral cortex
RGD
PMID:23028794
RGD:7204480
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
IEP
RGD
PMID:23028794
RGD:7204480
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12374626 PMID:21940958 PMID:25257527 PMID:29498696
RGD:13792833
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Il7r
interleukin 7 receptor
IEP
protein:increased expression:brain:
RGD
PMID:30676545
RGD:151347693
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Ina
internexin neuronal intermediate filament protein, alpha
ISO
RGD
PMID:29967576
RGD:27226878
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Inhba
inhibin subunit beta A
ISO
RGD
PMID:33345977
RGD:329845521
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Irf4
interferon regulatory factor 4
IEP
RGD
PMID:25652434
RGD:11530061
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO IMP
RGD
PMID:26661208 PMID:25477223 PMID:21750563
RGD:329955572 , RGD:401700383 , RGD:329955444
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Mag
myelin-associated glycoprotein
treatment
IMP
RGD
PMID:15678116
RGD:9685232
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:27152455 PMID:35218623
RGD:13800881 , RGD:401960864
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:27152455 PMID:35218623
RGD:13800881 , RGD:401960864
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapt
microtubule-associated protein tau
treatment
IEP IDA ISO
RGD
PMID:28886009 PMID:25903928 PMID:28886009
RGD:13800886 , RGD:13800913 , RGD:13800886
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mir107
microRNA 107
IEP
RNA:increased expression:brain
RGD
PMID:26294080
RGD:11553310
NCBI chr 1:232,337,767...232,337,853
Ensembl chr 1:232,337,767...232,337,853
G
Mir132
microRNA 132
treatment
ISO
mRNA:decreased expression:brain (mouse)
RGD
PMID:33763412 PMID:33763412
RGD:329849104 , RGD:329849104
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
G
Mir140
microRNA 140
ameliorates
ISO IEP
miRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:33246036 PMID:27035554
RGD:329337375 , RGD:329337377
NCBI chr19:35,465,577...35,465,675
Ensembl chr19:35,465,577...35,465,675
G
Mir19a
microRNA 19a
ISO
RNA:decreased expression:brain (mouse)
RGD
PMID:32335212
RGD:156451661
NCBI chr15:92,180,912...92,180,993
Ensembl chr15:92,180,912...92,180,993
G
Mir210
microRNA 210
treatment
IEP
RGD
PMID:34337881
RGD:155269103
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir29b1
microRNA 29b-1
exacerbates
IMP
RGD
PMID:35322553
RGD:242905190
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
G
Mir494
microRNA 494
ameliorates
ISO
RGD
PMID:32239566 PMID:31465536
RGD:155883173 , RGD:156430320
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
G
Mmp9
matrix metallopeptidase 9
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19309543 PMID:24842554
RGD:13204729
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mt3
metallothionein 3
IEP
protein:decreased expression:brain
RGD
PMID:8869568
RGD:9685807
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Mtor
mechanistic target of rapamycin kinase
treatment
IEP IDA
RGD
PMID:24583056 PMID:21185267 PMID:23777415
RGD:10040971 , RGD:10041016 , RGD:10040974
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nae1
NEDD8 activating enzyme E1 subunit 1
IEP
RGD
PMID:21386696
RGD:13801046
NCBI chr19:446,015...472,145
Ensembl chr19:446,000...472,371
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
IMP
RGD
PMID:28495827
RGD:13781880
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Ncam1
neural cell adhesion molecule 1
treatment
ISO IMP
RGD
PMID:32962079 PMID:29497380
RGD:40924633 , RGD:40925919
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Nefh
neurofilament heavy chain
ISO
RGD
PMID:29967576
RGD:27226878
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nefl
neurofilament light chain
ISO
protein:increased expression:brain
RGD
PMID:29967576
RGD:27226878
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
ISO
protein:altered expression:brain
RGD
PMID:29967576
RGD:27226878
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IDA
RGD
PMID:23880501 PMID:24466583
RGD:10412696 , RGD:10412714
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IEP
RGD
PMID:21122797
RGD:10413868
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Ngf
nerve growth factor
treatment
ISO IMP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10408807 PMID:29409115
RGD:402463967
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
treatment
IDA
RGD
PMID:22678884
RGD:10413900
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nod2
nucleotide-binding oligomerization domain containing 2
treatment
IEP
RGD
PMID:24842554
RGD:13204729
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
IEP ISO
protein:increased expression:brain (rat) mRNA:increased expression:brain (mouse)
RGD
PMID:21959178 PMID:22020035
RGD:5508751 , RGD:5509037
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nox1
NADPH oxidase 1
treatment
IEP
RGD
PMID:30816157
RGD:329955567
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
protein:increased expression:brain
RGD
PMID:21120604 PMID:25069640
RGD:5133239 , RGD:11035212
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nrg1
neuregulin 1
treatment ameliorates
ISO
RGD
PMID:20691195 PMID:30206770
RGD:10449015 , RGD:405650589
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Ogg1
8-oxoguanine DNA glycosylase
treatment
IEP
associated with Hypertension
RGD
PMID:17920569
RGD:8657395
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Park7
Parkinsonism associated deglycase
treatment
ISO
RGD
PMID:17882163
RGD:13463450
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
ISO IDA IEP
RGD
PMID:21311064 PMID:25882840 PMID:23143152 PMID:23801245
RGD:5683909 , RGD:13792686 , RGD:10054501 , RGD:11073732
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
treatment
ISO IEP
protein:increased expression:brain:
RGD
PMID:16403464 PMID:19352052 PMID:11323519
RGD:9835380 , RGD:9850083 , RGD:9835381
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pdgfra
platelet derived growth factor receptor alpha
treatment
IDA
RGD
PMID:16917016
RGD:11084934
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
treatment
IDA
RGD
PMID:16917016
RGD:11084934
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Plat
plasminogen activator, tissue type
IEP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12297567 PMID:17690543 PMID:18453163 PMID:20547619 PMID:29651748 PMID:14512838 More...
RGD:1580876
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11677890 PMID:15181847 PMID:17702958
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pld1
phospholipase D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
G
Prkcg
protein kinase C, gamma
ISO
RGD
PMID:14688616
RGD:1358416
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:24159062
RGD:11100027
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:15869933
RGD:9590118
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
Rbfox3
RNA binding fox-1 homolog 3
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
G
Reln
reelin
severity
ISO
RGD
PMID:16438965
RGD:13207538
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Rgma
repulsive guidance molecule BMP co-receptor a
treatment
IEP IMP
RGD
PMID:21840379 PMID:23275173
RGD:9850121 , RGD:9850122
NCBI chr 1:127,128,934...127,172,918
Ensembl chr 1:127,128,934...127,172,918
G
Rpl28
ribosomal protein L28
IEP
RGD
PMID:16805800
RGD:6480229
NCBI chr 1:69,052,148...69,054,735
Ensembl chr 1:69,053,203...69,055,032
G
Runx1
RUNX family transcription factor 1
IAGP
mRNA:increased expression:brain
RGD
PMID:24672479
RGD:11251714
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
S100a5
S100 calcium binding protein A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 2:176,095,332...176,099,546
Ensembl chr 2:176,097,539...176,099,546
G
S100b
S100 calcium binding protein B
IEP
protein:increased expression:cerebrum, astrocyte
RGD
PMID:23595285
RGD:401794586
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Serpine1
serpin family E member 1
IEP
RGD
PMID:14512838
RGD:1580876
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
treatment
IDA
RGD
PMID:22714093
RGD:8655545
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Serpinh1
serpin family H member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Shh
sonic hedgehog signaling molecule
treatment
ISO
RGD
PMID:22324418
RGD:12879461
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
treatment
IMP ISO
RGD
PMID:23600725 PMID:23600725
RGD:9585664 , RGD:9585664
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc12a2
solute carrier family 12 member 2
treatment
IMP ISO
protein:increased expression:brain:
RGD
PMID:12535773 PMID:27798271
RGD:1580583 , RGD:14398833
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
G
Slc1a2
solute carrier family 1 member 2
treatment
IEP
RGD
PMID:20423712
RGD:401794585
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc2a1
solute carrier family 2 member 1
treatment
IEP
RGD
PMID:9419067
RGD:12879855
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc9a1
solute carrier family 9 member A1
treatment
IMP
RGD
PMID:31250553
RGD:14985213
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Slpi
secretory leukocyte peptidase inhibitor
treatment
IEP
RGD
PMID:14500739
RGD:9999390
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Smo
smoothened, frizzled class receptor
treatment
IMP
RGD
PMID:23696546 PMID:23499832
RGD:12832759 , RGD:12879404
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Smox
spermine oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30576531
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
G
Snap91
synaptosome associated protein 91
IEP
protein:increased degradation:brain
RGD
PMID:19240038
RGD:13461853
NCBI chr 8:87,738,056...87,852,690
Ensembl chr 8:87,738,824...87,852,367
G
Sod1
superoxide dismutase 1
treatment
IDA IEP
mRNA, protein:increased expression:cerebral cortex (rat)
RGD
PMID:22001340 PMID:22133807
RGD:8657021 , RGD:8657023
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sphk2
sphingosine kinase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23043544
NCBI chr 1:96,180,872...96,188,592
Ensembl chr 1:96,180,887...96,188,391
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tgfb1
transforming growth factor, beta 1
ameliorates
IEP ISO
RGD
PMID:31409163 PMID:28630232
RGD:14995477 , RGD:242905192
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Th
tyrosine hydroxylase
IEP
protein:decreased expression:substantia nigra pars compacta, neuron (rat)
RGD
PMID:21366664
RGD:5128609
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
treatment ameliorates
IEP ISO IMP
RGD
PMID:24916922 PMID:28630232 PMID:35322553 PMID:15647744 PMID:29498696
RGD:10450594 , RGD:242905192 , RGD:242905190 , RGD:13825261 , RGD:13792833
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf1a
TNF receptor superfamily member 1A
IMP
RGD
PMID:15647744
RGD:13825261
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates
IDA
RGD
PMID:32736673
RGD:127284860
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Upp1
uridine phosphorylase 1
IEP
mRNA, protein:increased expression:brain (rat)
RGD
PMID:18457515
RGD:2317094
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Vegfa
vascular endothelial growth factor A
treatment
IMP IEP
mRNA,protein:increased expression:cerebral cortex (rat)
RGD
PMID:29497380 PMID:30531687 PMID:27035554
RGD:40925919 , RGD:329849008 , RGD:329337377
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
App
amyloid beta precursor protein
ISO
protein:decreased expression:cerebrospinal fluid:
RGD
PMID:1677459
RGD:10054257
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:18938189
RGD:10054050
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:18938189
RGD:10054050
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
IEP
RGD
PMID:21279683
RGD:10449132
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Il2
interleukin 2
severity
ISO
protein:increased secretion:mononuclear cell:
RGD
PMID:8586980
RGD:10047081
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Pnpo
pyridoxamine 5'-phosphate oxidase
ISO
ClinVar Annotator: match by term: Pyridoxal phosphate-responsive seizures CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:9536098 PMID:15182361 PMID:15772097 PMID:16199547 PMID:17216302 PMID:17576681 PMID:18296573 PMID:18485777 PMID:19759001 PMID:20370816 PMID:21292558 PMID:22858719 PMID:23419474 PMID:23430561 PMID:23708187 PMID:24266778 PMID:24297574 PMID:24645144 PMID:24658933 PMID:24781210 PMID:25256445 PMID:25741868 PMID:25762494 PMID:25979913 PMID:26467025 PMID:27014579 PMID:27419045 PMID:27781031 PMID:28133863 PMID:28349276 PMID:28492532 PMID:28929476 PMID:28985901 PMID:29588952 PMID:29610166 PMID:31440721 PMID:32395712 PMID:32788630 PMID:32888189 PMID:33087887 PMID:33981986 PMID:34177756 PMID:34769443 PMID:35217610 PMID:35495162 PMID:35636100 PMID:35715422 PMID:36007526 PMID:36106796 PMID:36801247 More...
NCBI chr10:81,924,584...81,930,844
Ensembl chr10:81,924,569...81,930,871
G
Acvrl1
activin A receptor like type 1
IEP
RGD
PMID:15781474
RGD:1579751
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:16630594
RGD:9681747
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
IEP
RGD
PMID:16630594
RGD:9681747
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adarb1
adenosine deaminase, RNA-specific, B1
IMP
RGD
PMID:16504947
RGD:10755337
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23437309
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
IEP ISO
protein:altered expression:cerebral cortex, striatum (rat) protein:increased expression:brain, plasma
RGD
PMID:22528836 PMID:23288172
RGD:7245542 , RGD:8696004
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
IEP
RGD
PMID:21934531
RGD:8549480
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
treatment
IMP
RGD
PMID:32913241
RGD:401793747
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP ISO
mRNA:decreased expression, altered localization:CA1 pyramidal layer, nucleus: protein:increased expression:nucleus:
RGD
PMID:14526224 PMID:15087715
RGD:10047409 , RGD:10053562
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Ang
angiogenin
treatment
IEP
RGD
PMID:30258350
RGD:155663419
NCBI chr15:24,312,711...24,323,361
G
Ank1
ankyrin 1
IEP
RGD
PMID:9202331
RGD:1599109
NCBI chr16:68,876,294...69,054,963
Ensembl chr16:68,877,504...69,054,759
G
Ank2
ankyrin 2
IEP
RGD
PMID:9202331
RGD:1599109
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
G
Apoe
apolipoprotein E
IEP
RGD
PMID:19623195
RGD:6903926
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aqp4
aquaporin 4
treatment
IEP
RGD
PMID:24773551
RGD:13207320
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Atf2
activating transcription factor 2
IDA IEP
RGD
PMID:10077326 PMID:9813301
RGD:10047405 , RGD:10047413
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atp5f1b
ATP synthase F1 subunit beta
IEP
protein:increased expression:cerebrum (rat)
RGD
PMID:21950801
RGD:13792582
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
G
Axin2
axin 2
treatment
IEP
RGD
PMID:31650542
RGD:151356749
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Bace1
beta-secretase 1
IEP
protein:increased activity,increased expression:brain cortex
RGD
PMID:15120577
RGD:13782170
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Bad
BCL2-associated agonist of cell death
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12629175
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:21167243
RGD:10054102
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
IEP
protein:increased expression:hippocampus CA1, pyramidal cell
RGD
PMID:12913114
RGD:634629
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP IDA
protein:decreased expression:brain
RGD
PMID:18083315 PMID:22509406 PMID:16732092
RGD:2290557 , RGD:11561910 , RGD:11522725
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l2
Bcl2-like 2
treatment
IEP ISO
protein:increased expression:cortex and caudate putamen
RGD
PMID:10724126 PMID:12571640
RGD:14394498 , RGD:14394500
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:22509406
RGD:11561910
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bex3
brain expressed X-linked 3
IEP
RGD
PMID:11124986
RGD:9743974
NCBI chr X:99,273,270...99,274,799
Ensembl chr X:99,273,161...99,274,800
G
Bnip3
BCL2 interacting protein 3
IEP
RGD
PMID:14972662
RGD:2314028
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23199288 PMID:22004711
RGD:7411628
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cab39
calcium binding protein 39
IEP
protein:increased expression:brain
RGD
PMID:27798271
RGD:14398833
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
IEP ISO
protein:increased expression:hippocampus
RGD
PMID:12951199 PMID:12199152
RGD:7241547 , RGD:13681927
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Casp3
caspase 3
IDA
RGD
PMID:21712070
RGD:10053706
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
IEP
RGD
PMID:25872160
RGD:13782285
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
treatment
IEP
protein:increased expression:cerebral cortex:
RGD
PMID:30148677 PMID:18096138
RGD:13782286 , RGD:4142863
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
IEP ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:neocortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:15246841 PMID:21712070
RGD:2311321 , RGD:10053706
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
treatment
IEP ISO
RGD
PMID:22007835 PMID:22007835
RGD:8661794 , RGD:8661794
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cbl
Cbl proto-oncogene
treatment
IDA
RGD
PMID:18773943
RGD:4108486
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Cbs
cystathionine beta synthase
treatment
ISO
XCO:0000348 XCO:0000807
RGD
PMID:22212488 PMID:22212488
RGD:41410880 , RGD:41410880
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA IEP
mRNA:increased expression:brain (rat)
RGD
PMID:21487414 PMID:7860708
RGD:8549519 , RGD:8549729
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
treatment
IMP
RGD
PMID:19428685
RGD:7488896
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccnh
cyclin H
IEP
mRNA, protein:increased expression:hippocampus
RGD
PMID:10501206
RGD:69371
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
G
Ccr6
C-C motif chemokine receptor 6
IEP
mRNA:increased expression:brain
RGD
PMID:19428685
RGD:7488896
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Cd40
CD40 molecule
severity
ISO
RGD
PMID:15795333
RGD:11352234
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
severity
ISO
RGD
PMID:15795333
RGD:11352234
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cdk5
cyclin-dependent kinase 5
treatment
IEP
RGD
PMID:28254431
RGD:13506925
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
protein:decreased expression:striatum, neuron
RGD
PMID:11438580
RGD:8552691
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cebpa
CCAAT/enhancer binding protein alpha
IEP
mRNA, protein:increased expression:hippocampal pyramidal cell layer (rat)
RGD
PMID:9795105
RGD:10401192
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Chka
choline kinase alpha
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:16300643
RGD:10401831
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Coq7
coenzyme Q7, hydroxylase
severity
ISO
RGD
PMID:20170652
RGD:10402096
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
G
Creb1
cAMP responsive element binding protein 1
IDA
RGD
PMID:10077326
RGD:10047405
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crem
cAMP responsive element modulator
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12437578
RGD:632385
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:12624302
RGD:10450512
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP
mRNA,protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP
protein:increased expression:hippocampus:
RGD
PMID:24924806
RGD:11352662
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cycs
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11333366
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Daxx
death-domain associated protein
treatment
IDA IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:17967739 PMID:18096138
RGD:9587802 , RGD:4142863
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Dbn1
drebrin 1
IEP
RGD
PMID:8583659
RGD:10398814
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
G
Dffb
DNA fragmentation factor subunit beta
IEP
mRNA, protein:increased expression:hippocampus CA1
RGD
PMID:11425895
RGD:628524
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dll4
delta like canonical Notch ligand 4
ameliorates treatment disease_progression
ISO IEP
RGD
PMID:31927543 PMID:30258350 PMID:30653356
RGD:155663354 , RGD:155663419 , RGD:155663383
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Dusp1
dual specificity phosphatase 1
IEP
protein:increased expression:brain
RGD
PMID:22197701
RGD:7771582
NCBI chr10:16,680,478...16,683,275
G
Dusp16
dual specificity phosphatase 16
IEP
protein:increased expression, altered localization:hippocampus, cytosol, nucleus
RGD
PMID:23280045
RGD:7775014
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Eed
embryonic ectoderm development
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
ISO IEP
associated with Heart Arrest
RGD
PMID:11520898 PMID:10541873
RGD:10395353 , RGD:11041881
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:19168036
RGD:10450558
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Elk1
ETS transcription factor ELK1
treatment
IEP
RGD
PMID:17091294
RGD:7488902
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
IEP
mRNA:increased expression:brain:
RGD
PMID:9634555
RGD:9685492
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Ep300
E1A binding protein p300
IEP
mRNA:increased expression:cerebrum, ipsilateral side (rat)
RGD
PMID:22196858
RGD:7349341
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epo
erythropoietin
treatment
IEP ISO
RGD
PMID:22282883 PMID:24702327
RGD:10401060 , RGD:11041699
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
ISO
human gene in a rat model
RGD
PMID:19440222
RGD:2313668
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:10437118
RGD:10401104
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
G
Esr1
estrogen receptor 1
treatment
IDA
RGD
PMID:24548484 PMID:25098259
RGD:10045843 , RGD:10045845
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:23593292
RGD:7364962
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F11r
F11 receptor
treatment
IEP
RGD
PMID:22868201
RGD:7488943
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
F12
coagulation factor XII
treatment
ISO
RGD
PMID:16533887 PMID:16533887
RGD:11041786 , RGD:11041786
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
Fadd
Fas associated via death domain
IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IEP IDA ISO
protein:increased expression:brain protein:increased expression:brain (rat)
RGD
PMID:18410517 PMID:30301943 PMID:18981705 PMID:10972965
RGD:2311437 , RGD:153297779 , RGD:8686422 , RGD:8662928
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fgfr1
Fibroblast growth factor receptor 1
IEP
mRNA:increased expression:cerebral cortex:
RGD
PMID:8858623
RGD:10402044
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Fgfr2
fibroblast growth factor receptor 2
treatment
IEP
associated with Experimental Diabetes Mellitus
RGD
PMID:22432030
RGD:155882598
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Flt1
Fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:17077813
RGD:10402150
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fmr1
fragile X messenger ribonucleoprotein 1
IEP
mRNA, protein:increased expression:striatum (rat)
RGD
PMID:22817682
RGD:11566024
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
IEP ISO
protein:decreased expression:cerebral cortex mRNA:decreased expression:cerebral cortex mRNA:decreased expression:heart
RGD
PMID:32426101 PMID:36479246 PMID:34413770
RGD:329901764 , RGD:329951019 , RGD:329901768
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
G
G6pd
glucose-6-phosphate dehydrogenase
IMP
RGD
PMID:22580330
RGD:10449127
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gad1
glutamate decarboxylase 1
disease_progression
IEP
RGD
PMID:20659561
RGD:401900597
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
disease_progression
IEP
RGD
PMID:20659561
RGD:401900597
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
G
Gamt
guanidinoacetate N-methyltransferase
ameliorates
ISO
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
G
Gatm
glycine amidinotransferase
exacerbates
ISO
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gch1
GTP cyclohydrolase 1
treatment
IMP
RGD
PMID:9920651
RGD:329961573
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Ghsr
growth hormone secretagogue receptor
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:17560544
RGD:12907500
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
G
Gja1
gap junction protein, alpha 1
treatment
ISO IEP
protein:increased expression:brain
RGD
PMID:22812228 PMID:23328809
RGD:7207263 , RGD:8662426
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gjb6
gap junction protein, beta 6
IEP
protein:increased expression:hippocampus:
RGD
PMID:21718970
RGD:6480433
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
G
Glrx
glutaredoxin
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:10329397
RGD:9686043
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glul
glutamate-ammonia ligase
treatment
IEP
associated with carotid artery occlusion protein:increased expression:hippocampus
RGD
PMID:27664163 PMID:25365917 PMID:21272618 PMID:21371894
RGD:401794415 , RGD:401794591 , RGD:401794590 , RGD:401794419
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Got1
glutamic-oxaloacetic transaminase 1
treatment
ISO IDA
human protein in a rat model
RGD
PMID:24407245 PMID:21361730 PMID:20145654
RGD:13504852 , RGD:13504855 , RGD:13504854
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gp6
glycoprotein VI
ameliorates
ISO
RGD
PMID:34237320
RGD:401794450
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:30098076
RGD:401827833
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ameliorates treatment
IMP IDA ISO
associated with hyperhomocysteinemia
RGD
PMID:30885791 PMID:12932824 PMID:30885791
RGD:401940141 , RGD:401950480 , RGD:401940141
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
ameliorates
IMP
RGD
PMID:30885791
RGD:401940141
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Gsr
glutathione-disulfide reductase
treatment
IDA
RGD
PMID:15525350
RGD:10401855
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
H2ax
H2A.X variant histone
treatment
IDA
RGD
PMID:20830300
RGD:8693742
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Havcr2
hepatitis A virus cellular receptor 2
treatment
IEP
RGD
PMID:24771108
RGD:9686115
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP
protein:increased expression:cerebral cortex, caudoputamen (rat)
RGD
PMID:20417628 PMID:30258350
RGD:9068877 , RGD:155663419
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:brain, plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
IEP
protein:altered expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20421594
RGD:10041006
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
treatment
IDA
RGD
PMID:22366221
RGD:9999181
NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
G
Hrh2
histamine receptor H 2
IEP
protein:decreased expression:caudate putamen (rat)
RGD
PMID:16181737
RGD:9685533
NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631
G
Hsf1
heat shock transcription factor 1
treatment
IEP IDA
protein:increased expression:brain, nucleus (rat) associated with Heart Arrest
RGD
PMID:26070787 PMID:23528677
RGD:10402389 , RGD:10402772
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
RGD
PMID:25632565
RGD:11354959
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
protein:increased expression:brain, postsynaptic density (rat)
RGD
PMID:9425004
RGD:10059344
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb1
heat shock protein family B (small) member 1
IEP
protein:increased expression:brain,astrocyte:
RGD
PMID:10559386
RGD:10402577
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Htra2
HtrA serine peptidase 2
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15306124 PMID:19462455
RGD:10402932
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
G
Htt
huntingtin
IEP
protein:increased degradation:brain
RGD
PMID:12957494
RGD:1304431
NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:22379785
RGD:8547729
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifnb1
interferon beta 1
ameliorates
IDA
RGD
PMID:12973019
RGD:401851924
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Igf1
insulin-like growth factor 1
severity
IEP
protein:decreased expression:serum (rat)
RGD
PMID:25098324
RGD:12904924
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IEP
RGD
PMID:24261295
RGD:7495766
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:24053818
RGD:7364868
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
IDA ISO
RGD
PMID:23147509 PMID:22284622
RGD:7175551 , RGD:7175554
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
IDA ISO
human protein in a rat model
RGD
PMID:15837124 PMID:20412072
RGD:1626674 , RGD:8551852
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Ilk
integrin-linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15472100
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
G
Itgam
integrin subunit alpha M
treatment
ISO IEP IMP
mRNA:increased expression:cerebral cortex (mouse) mRNA:increased expression:brain (rat)
RGD
PMID:30123113 PMID:23844255 PMID:22082476 PMID:32407868 PMID:19563786 PMID:8964796 PMID:8581506 PMID:8160235 More...
RGD:329853754 , RGD:329902067 , RGD:329902058 , RGD:329901940 , RGD:329901933 , RGD:329901921 , RGD:329901917 , RGD:329901916
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgb3
integrin subunit beta 3
IEP
RGD
PMID:18638458
RGD:6907424
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
IEP
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:7500836
RGD:6482813
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Jak1
Janus kinase 1
IEP
RGD
PMID:10756075
RGD:19165138
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
IDA
RGD
PMID:23764464
RGD:8694326
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
IEP
protein:decreased expression:CA1 field of hippocampus, astrocyte, astrocyte projection
RGD
PMID:20833221
RGD:8662899
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
G
Kcnk2
potassium two pore domain channel subfamily K member 2
severity treatment
ISO IDA IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15175651 PMID:24154701 PMID:25062759
RGD:9831121 , RGD:9831178 , RGD:9831122
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kdm1a
lysine demethylase 1A
IEP
protein:increased expression:cerebral cortex, hippocampus, dentate gyrus (rat)
RGD
PMID:20542065
RGD:9588301
NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
G
Keap1
Kelch-like ECH-associated protein 1
ISO
protein:decreased expression:brain (mouse)
RGD
PMID:21075092
RGD:6893270
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Klf5
KLF transcription factor 5
ameliorates
IMP
RGD
PMID:32272873
RGD:45073134
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Kmt2a
lysine methyltransferase 2A
treatment
IMP
RGD
PMID:34694864
RGD:155888565
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Lcn2
lipocalin 2
IEP
protein:increased expression:brain
RGD
PMID:29122651 PMID:24916903
RGD:126781757 , RGD:126790489
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lmna
lamin A/C
IDA
RGD
PMID:17683050
RGD:2293745
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lpar1
lysophosphatidic acid receptor 1
treatment
IDA
RGD
PMID:17173873
RGD:9850154
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Ltbp1
latent transforming growth factor beta binding protein 1
treatment
IEP
RGD
PMID:11720783
RGD:10412057
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Madd
MAP-kinase activating death domain
IEP
RGD
PMID:12625816
RGD:9588641
NCBI chr 3:77,114,330...77,157,865
Ensembl chr 3:77,114,314...77,157,701
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP
RGD
PMID:22509406
RGD:11561910
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map2k4
mitogen activated protein kinase kinase 4
IDA
protein:increased threonine phosphorylation:heart, nucleus
RGD
PMID:9195981
RGD:7495830
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
IEP
protein:increased nitrosylation, activity:hippocampus:
RGD
PMID:23137546
RGD:10412334
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates
ISO
RGD
PMID:32078472 PMID:32349637 PMID:34628598 PMID:32382778
RGD:155791642 , RGD:155804284 , RGD:155804283 , RGD:155804272
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Map4k1
mitogen activated protein kinase kinase kinase kinase 1
treatment
IDA
RGD
PMID:18498770 PMID:18382279
RGD:7495845 , RGD:7495847
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
G
Mbd1
methyl-CpG binding domain protein 1
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:67,869,870...67,884,501
Ensembl chr18:67,869,992...67,886,554
G
Mbd2
methyl-CpG binding domain protein 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mbd3
methyl-CpG binding domain protein 3
IEP
mRNA:decreased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
G
Mbp
myelin basic protein
IEP
mRNA:increased expression:oligodendrocyte:
RGD
PMID:11460777
RGD:7349336
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17610559
RGD:11062141
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
G
Mdm2
MDM2 proto-oncogene
treatment
IDA
RGD
PMID:24334056
RGD:10412310
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mecp2
methyl CpG binding protein 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Mff
mitochondrial fission factor
treatment
IDA
RGD
PMID:26116440
RGD:12879457
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
G
Mfn2
mitofusin 2
IEP
protein:decreased expression:brain (rat)
RGD
PMID:25147362
RGD:13204807
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mir126a
microRNA 126a
exacerbates
ISO
RGD
PMID:28101763
RGD:401850574
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
G
Mir155
microRNA 155
treatment
IEP
RGD
PMID:33081480
RGD:151347423
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir195
microRNA 195
severity
IMP
RGD
PMID:32272873
RGD:45073134
NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
G
Mir223
microRNA 223
IMP
RGD
PMID:31237865
RGD:25824937
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mmp2
matrix metallopeptidase 2
treatment
IDA IEP
protein:increased activity, increased expression:brain
RGD
PMID:11592852 PMID:24828425
RGD:8547930 , RGD:8657086
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
ISO IEP IDA
protein:increased activity, increased expression:brain
RGD
PMID:16197500 PMID:24773551 PMID:23046750 PMID:11592852
RGD:8547921 , RGD:13207320 , RGD:13207323 , RGD:8547930
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mt1
metallothionein 1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mt3
metallothionein 3
IEP
mRNA, protein:increased expression:brain
RGD
PMID:10069533
RGD:9685804
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Mtor
mechanistic target of rapamycin kinase
treatment
IEP
RGD
PMID:30712471
RGD:155791663
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Myb
MYB proto-oncogene, transcription factor
IEP
mRNA:increased expression:brain:
RGD
PMID:24828495
RGD:11532683
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
IMP ISO
RGD
PMID:28528966 PMID:25603815
RGD:13781879 , RGD:13781895
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Ndrg2
NDRG family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23451161
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Ndrg4
NDRG family member 4
ISO
RGD
PMID:21636852
RGD:7247728
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
G
Nefh
neurofilament heavy chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nefl
neurofilament light chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Nf1
neurofibromin 1
IEP
mRNA,protein:increased expression:astrocyte:
RGD
PMID:8820972
RGD:12789703
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
G
Nfkb1
nuclear factor kappa B subunit 1
IEP
protein:increased expression:hippocampal pyramidal neuron, nucleus (rat)
RGD
PMID:9158652
RGD:10045943
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Ngb
neuroglobin
treatment
IEP ISO IMP
associated with Hypertension;mRNA, protein:decreased expression:brain
RGD
PMID:16647691 PMID:23342777 PMID:12621155 PMID:12621155
RGD:9743952 , RGD:9743965 , RGD:9743964 , RGD:9743964
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
G
Ngfr
nerve growth factor receptor
IEP
RGD
PMID:11124986
RGD:9743974
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
mRNA, protein:increased expression:brain
RGD
PMID:20863826
RGD:5508733
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nono
non-POU domain containing, octamer-binding
ISO
protein:altered localization:cerebral cortex (mouse)
RGD
PMID:29426953
RGD:155883175
NCBI chr X:66,554,131...66,571,992
Ensembl chr X:66,554,098...66,571,952
G
Nos1
nitric oxide synthase 1
IDA
protein:increased serine phosphorylation:dentate gyrus
RGD
PMID:23806217
RGD:7257600
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos3
nitric oxide synthase 3
treatment
IEP IDA
protein:increased expression:serum (rat)
RGD
PMID:28944915 PMID:29298658 PMID:29312485
RGD:13450951 , RGD:13503353 , RGD:13503330
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Notch1
notch receptor 1
treatment
IEP
RGD
PMID:30258350
RGD:155663419
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nox1
NADPH oxidase 1
ameliorates
IMP
RGD
PMID:25617620
RGD:329955357
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
protein:increased expression:cerebral cortex (rat) protein:increased expression:brain (rat)
RGD
PMID:29017857 PMID:28169530 PMID:28552673
RGD:13439718 , RGD:13442499 , RGD:13439727
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nrg1
neuregulin 1
treatment ameliorates
ISO
RGD
PMID:31560696 PMID:30206770
RGD:405649728 , RGD:405650589
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nrp1
neuropilin 1
IEP
mRNA:increased expression:brain
RGD
PMID:33675584
RGD:401901171
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nrxn1
neurexin 1
IEP
associated with Hypertension;mRNA:decreased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
G
Ogg1
8-oxoguanine DNA glycosylase
IEP
protein:increased expression:cerebral cortex
RGD
PMID:14600440
RGD:8657406
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Opa1
OPA1, mitochondrial dynamin like GTPase
treatment
ISO IDA
protein:altered expression:brain
RGD
PMID:22345048 PMID:24633199
RGD:7800722 , RGD:13208946
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Optn
optineurin
IEP
protein:decreased expression:cerebral cortex (rat)
RGD
PMID:24235151
RGD:13434905
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
G
Parl
presenilin associated, rhomboid-like
severity
ISO
RGD
PMID:23921894
RGD:12902620
NCBI chr11:80,594,059...80,620,506
Ensembl chr11:80,593,192...80,620,506
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
IDA IEP
RGD
PMID:19840223 PMID:19840223
RGD:2325713 , RGD:2325713
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
IEP ISO
mRNA:increased expression:brain: protein:increased expression:cortex,striatum:
RGD
PMID:14705148 PMID:11323519
RGD:1302269 , RGD:9835381
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pax6
paired box 6
IEP
protein:increased expression:cerebral cortex, striatum, astroglial cell (rat)
RGD
PMID:24114637
RGD:8552354
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Pcna
proliferating cell nuclear antigen
IEP
RGD
PMID:9757027
RGD:10448974
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pde4d
phosphodiesterase 4D
IEP
protein:increased expression:hippocampus CA1
RGD
PMID:22860212
RGD:7327148
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
G
Pdyn
prodynorphin
IEP
mRNA:decreased expression:dentate gyrus, granule cell
RGD
PMID:8914861
RGD:401851049
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:brain (mouse)
RGD
PMID:22382321
RGD:6766379
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Plat
plasminogen activator, tissue type
IEP
Protein:increased expression, increased activity:hippocampus (rat)
RGD
PMID:15882815
RGD:1580875
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
IEP IDA
protein:increased expression:cerebral cortex (rat)
RGD
PMID:21375013 PMID:19952306
RGD:7241584 , RGD:7241795
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plxnd1
plexin D1
ameliorates
IMP
RGD
PMID:30653356
RGD:155663383
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
G
Pparg
peroxisome proliferator-activated receptor gamma
IMP IEP
RGD
PMID:18378216 PMID:19221220 PMID:18973594
RGD:2301892 , RGD:8553032 , RGD:2301866
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15255948
RGD:9999154
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
treatment
IDA
RGD
PMID:21278085
RGD:10043805
NCBI chr 4:32,970,501...33,292,360
Ensembl chr 4:33,024,450...33,286,907
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
treatment
IEP
RGD
PMID:30712471
RGD:155791663
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:decreased expression:cerebral cortex, striatum:
RGD
PMID:12415119
RGD:10413862
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Ptafr
platelet-activating factor receptor
treatment
IEP IMP
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:17268849 PMID:8158141
RGD:9999221 , RGD:10043297
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Pten
phosphatase and tensin homolog
IEP
RGD
PMID:12414116
RGD:1358425
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptger4
prostaglandin E receptor 4
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:16437207
RGD:10043375
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgis
prostaglandin I2 synthase
treatment
IMP
RGD
PMID:27834752
RGD:401960086
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Ptn
pleiotrophin
IEP
mRNA:increased expression:cerebral cortex, vasculature, macrophage (rat)
RGD
PMID:9570800
RGD:9831440
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
severity treatment
IEP ISO IDA
protein:decreased phosphorylation, decreased expression:striatum (rat)
RGD
PMID:24198371 PMID:24198371 PMID:24198371
RGD:9835010 , RGD:9835010 , RGD:9835010
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
G
Rack1
receptor for activated C kinase 1
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
G
Robo1
roundabout guidance receptor 1
disease_progression
IEP ISO
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:23473743 PMID:27686659
RGD:11573340 , RGD:243048431 , RGD:243048429
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
G
Robo2
roundabout guidance receptor 2
IEP
protein:increased expression:brain, astrocyte
RGD
PMID:27686659
RGD:243048429
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
G
Robo4
roundabout guidance receptor 4
IEP
protein:increased expression:hippocampus
RGD
PMID:26764532
RGD:11573340
NCBI chr 8:37,119,953...37,133,887
Ensembl chr 8:37,119,988...37,132,519
G
Rps6
ribosomal protein S6
IDA
RGD
PMID:26556340
RGD:11041643
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Sema3e
semaphorin 3E
disease_progression
IEP
RGD
PMID:30653356
RGD:155663383
NCBI chr 4:20,297,534...20,555,287
Ensembl chr 4:20,299,718...20,555,229
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:26851971
RGD:11073692
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
treatment
ISO
human gene in a rat model
RGD
PMID:18624913
RGD:8613878
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Sgk1
serum/glucocorticoid regulated kinase 1
IEP
mRNA:increased expression:hippocampus, pyramidal cell
RGD
PMID:15046873
RGD:1580967
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sin3a
SIN3 transcription regulator family member A
IDA
RGD
PMID:24063527
RGD:9495912
NCBI chr 8:57,481,539...57,536,195
Ensembl chr 8:57,481,573...57,536,192
G
Sirt6
sirtuin 6
IEP
mRNA, protein:decreased expression:brain
RGD
PMID:23899523
RGD:9586062
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
G
Slc12a2
solute carrier family 12 member 2
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
G
Slc17a6
solute carrier family 17 member 6
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Slc17a7
solute carrier family 17 member 7
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc17a8
solute carrier family 17 member 8
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
G
Slit2
slit guidance ligand 2
IEP
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:27686659
RGD:11573340 , RGD:243048429
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Smpd3
sphingomyelin phosphodiesterase 3
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
G
Socs1
suppressor of cytokine signaling 1
treatment
IEP
RGD
PMID:33081480
RGD:151347423
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Sod1
superoxide dismutase 1
treatment
ISO
human protein in a rat model CTD Direct Evidence: therapeutic human gene in a rat model
CTD RGD
PMID:12629175 PMID:15829915 PMID:16538228 PMID:16868554 PMID:21531066 PMID:17110031 More...
RGD:8655885 , RGD:8655986
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:30716316
RGD:27095883
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Stat3
signal transducer and activator of transcription 3
exacerbates
IDA IMP
RGD
PMID:23764464 PMID:23884942
RGD:8694326 , RGD:8694331
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tert
telomerase reverse transcriptase
treatment
IDA
RGD
PMID:21914402
RGD:11038669
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:18067952
RGD:11062087
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tia1
TIA1 cytotoxic granule-associated RNA binding protein
IEP
RGD
PMID:16055272
RGD:10059581
NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
IEP
RGD
PMID:10700014
RGD:1357161
NCBI chr 1:183,008,358...183,045,092
Ensembl chr 1:183,009,253...183,031,637
G
Tnf
tumor necrosis factor
treatment
IDA IEP
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:24053818 PMID:11412877
RGD:7364868 , RGD:13825263
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IEP
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:21868309 PMID:11412877
RGD:8661762 , RGD:13825263
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
treatment
IDA ISO
RGD
PMID:23435869 PMID:20811149 PMID:23043486
RGD:7247582 , RGD:7247585 , RGD:7247583
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:16777714
RGD:10003026
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
ISO
RGD
PMID:22284622
RGD:7175554
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Ucp2
uncoupling protein 2
treatment
IDA
RGD
PMID:19772611
RGD:7204428
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Vwf
von Willebrand factor
treatment
IDA
RGD
PMID:22771326
RGD:7207039
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wnk1
WNK lysine deficient protein kinase 1
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr 4:153,128,334...153,253,905
Ensembl chr 4:153,128,334...153,253,905
G
Wnk2
WNK lysine deficient protein kinase 2
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr17:15,503,672...15,612,479
Ensembl chr17:15,504,261...15,612,479
G
Wnk4
WNK lysine deficient protein kinase 4
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr10:86,202,552...86,219,655
Ensembl chr10:86,188,812...86,231,829
G
Xrcc1
X-ray repair cross complementing 1
treatment
IEP
RGD
PMID:19840223
RGD:2325713
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all